{"id": "train_6_0", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in @DISEASE$ (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in [E2]@DISEASE$[/E2] (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with Joubert and Meckel syndromes, whereas hypomorphic mutations result in [DISEASE]@DISEASE$[/DISEASE] (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [157, 166], "entity_2_idx_in_text_with_entity_marker": [170, 179], "entity_2_idx_in_text_with_typed_entity_marker": [179, 188], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_1", "text": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on @GENE$ levels in chronic kidney disease (@DISEASE$) patients before and after a successful kidney transplantation.", "text_with_entity_marker": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on [E1]@GENE$[/E1] levels in chronic kidney disease ([E2]@DISEASE$[/E2]) patients before and after a successful kidney transplantation.", "text_with_typed_entity_marker": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on [GENE]@GENE$[/GENE] levels in chronic kidney disease ([DISEASE]@DISEASE$[/DISEASE]) patients before and after a successful kidney transplantation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [137, 143], "entity_1_idx_in_text_with_entity_marker": [141, 147], "entity_1_idx_in_text_with_typed_entity_marker": [143, 149], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [178, 187], "entity_2_idx_in_text_with_entity_marker": [191, 200], "entity_2_idx_in_text_with_typed_entity_marker": [200, 209], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_2", "text": "Lack of association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and [E2]@DISEASE$[/E2], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [60, 69], "entity_2_idx_in_text_with_entity_marker": [73, 82], "entity_2_idx_in_text_with_typed_entity_marker": [82, 91], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_3", "text": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of @GENE$ variant.", "text_with_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [E1]@DISEASE$[/E1] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of [E2]@GENE$[/E2] variant.", "text_with_typed_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and rs2198843 variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [DISEASE]@DISEASE$[/DISEASE] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of [GENE]@GENE$[/GENE] variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [188, 197], "entity_1_idx_in_text_with_entity_marker": [192, 201], "entity_1_idx_in_text_with_typed_entity_marker": [197, 206], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [265, 271], "entity_2_idx_in_text_with_entity_marker": [278, 284], "entity_2_idx_in_text_with_typed_entity_marker": [290, 296], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_4", "text": "Functional studies to unravel the biological significance of this region in regulating @GENE$ production is clearly indicated, which may lead to new strategies to modify the disease course of severe @DISEASE$.", "text_with_entity_marker": "Functional studies to unravel the biological significance of this region in regulating [E1]@GENE$[/E1] production is clearly indicated, which may lead to new strategies to modify the disease course of severe [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Functional studies to unravel the biological significance of this region in regulating [GENE]@GENE$[/GENE] production is clearly indicated, which may lead to new strategies to modify the disease course of severe [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [87, 93], "entity_1_idx_in_text_with_entity_marker": [91, 97], "entity_1_idx_in_text_with_typed_entity_marker": [93, 99], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [199, 208], "entity_2_idx_in_text_with_entity_marker": [212, 221], "entity_2_idx_in_text_with_typed_entity_marker": [221, 230], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_5", "text": "We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and [E2]@DISEASE$[/E2], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_6", "text": "Expression of VEGFR-1 (Flt-1) in @DISEASE$ is associated with @GENE$ expression and with node-negative tumour stage.", "text_with_entity_marker": "Expression of VEGFR-1 (Flt-1) in [E1]@DISEASE$[/E1] is associated with [E2]@GENE$[/E2] expression and with node-negative tumour stage.", "text_with_typed_entity_marker": "Expression of VEGFR-1 (Flt-1) in [DISEASE]@DISEASE$[/DISEASE] is associated with [GENE]@GENE$[/GENE] expression and with node-negative tumour stage.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [33, 42], "entity_1_idx_in_text_with_entity_marker": [37, 46], "entity_1_idx_in_text_with_typed_entity_marker": [42, 51], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [62, 68], "entity_2_idx_in_text_with_entity_marker": [75, 81], "entity_2_idx_in_text_with_typed_entity_marker": [87, 93], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_7", "text": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of @GENE$ (previously known as CIAS1 and NALP3) that are associated with @DISEASE$.", "text_with_entity_marker": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of [E1]@GENE$[/E1] (previously known as CIAS1 and NALP3) that are associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of [GENE]@GENE$[/GENE] (previously known as CIAS1 and NALP3) that are associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [135, 141], "entity_1_idx_in_text_with_entity_marker": [139, 145], "entity_1_idx_in_text_with_typed_entity_marker": [141, 147], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [205, 214], "entity_2_idx_in_text_with_entity_marker": [218, 227], "entity_2_idx_in_text_with_typed_entity_marker": [227, 236], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_8", "text": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of @GENE$ (CypA) and susceptibility to both HIV-1 @DISEASE$ and disease progression.", "text_with_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of [E1]@GENE$[/E1] (CypA) and susceptibility to both HIV-1 [E2]@DISEASE$[/E2] and disease progression.", "text_with_typed_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of [GENE]@GENE$[/GENE] (CypA) and susceptibility to both HIV-1 [DISEASE]@DISEASE$[/DISEASE] and disease progression.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [101, 107], "entity_1_idx_in_text_with_entity_marker": [105, 111], "entity_1_idx_in_text_with_typed_entity_marker": [107, 113], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [148, 157], "entity_2_idx_in_text_with_entity_marker": [161, 170], "entity_2_idx_in_text_with_typed_entity_marker": [170, 179], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_9", "text": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to His1104Asp or @GENE$ genotypes.", "text_with_entity_marker": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or [E1]@DISEASE$[/E1] compared to His1104Asp or [E2]@GENE$[/E2] genotypes.", "text_with_typed_entity_marker": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or [DISEASE]@DISEASE$[/DISEASE] compared to His1104Asp or [GENE]@GENE$[/GENE] genotypes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [97, 106], "entity_1_idx_in_text_with_entity_marker": [101, 110], "entity_1_idx_in_text_with_typed_entity_marker": [106, 115], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [133, 139], "entity_2_idx_in_text_with_entity_marker": [146, 152], "entity_2_idx_in_text_with_typed_entity_marker": [158, 164], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_10", "text": "@DISEASE$ patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired @GENE$-dependent down-regulation of TNF-alpha secretion.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired [E2]@GENE$[/E2]-dependent down-regulation of TNF-alpha secretion.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired [GENE]@GENE$[/GENE]-dependent down-regulation of TNF-alpha secretion.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [119, 125], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_idx_in_text_with_typed_entity_marker": [144, 150], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_11", "text": "For men, G allele frequency of @GENE$ and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for @DISEASE$ patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "text_with_entity_marker": "For men, G allele frequency of [E1]@GENE$[/E1] and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for [E2]@DISEASE$[/E2] patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "text_with_typed_entity_marker": "For men, G allele frequency of [GENE]@GENE$[/GENE] and frequency of the T-C-G haplotype were significantly higher, and frequency of the T-C-A haplotype was significantly lower for [DISEASE]@DISEASE$[/DISEASE] patients than for controls (P=0.006, P=0.001 and P=0.002, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [167, 176], "entity_2_idx_in_text_with_entity_marker": [180, 189], "entity_2_idx_in_text_with_typed_entity_marker": [189, 198], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_12", "text": "This study is the first to confirm the association between @GENE$ and @DISEASE$.", "text_with_entity_marker": "This study is the first to confirm the association between [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "This study is the first to confirm the association between [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [59, 65], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_idx_in_text_with_typed_entity_marker": [65, 71], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_13", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor (@GENE$) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([E1]@GENE$[/E1]) locus and [E2]@DISEASE$[/E2] (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), rs11209026, within the interleukin-23 receptor ([GENE]@GENE$[/GENE]) locus and [DISEASE]@DISEASE$[/DISEASE] (CD) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [132, 138], "entity_1_idx_in_text_with_entity_marker": [136, 142], "entity_1_idx_in_text_with_typed_entity_marker": [138, 144], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [150, 159], "entity_2_idx_in_text_with_entity_marker": [163, 172], "entity_2_idx_in_text_with_typed_entity_marker": [172, 181], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_14", "text": "Individual LOXL1 SNPs, rs1048661, rs3825942, and @GENE$, were not associated with @DISEASE$ in the Chinese population.", "text_with_entity_marker": "Individual LOXL1 SNPs, rs1048661, rs3825942, and [E1]@GENE$[/E1], were not associated with [E2]@DISEASE$[/E2] in the Chinese population.", "text_with_typed_entity_marker": "Individual LOXL1 SNPs, rs1048661, rs3825942, and [GENE]@GENE$[/GENE], were not associated with [DISEASE]@DISEASE$[/DISEASE] in the Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [49, 55], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 61], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_15", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([E1]@GENE$[/E1] in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([GENE]@GENE$[/GENE] in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [223, 229], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_idx_in_text_with_typed_entity_marker": [229, 235], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [257, 266], "entity_2_idx_in_text_with_entity_marker": [270, 279], "entity_2_idx_in_text_with_typed_entity_marker": [279, 288], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_16", "text": "Fetal haemoglobin (@GENE$) level modifies the clinical severity of @DISEASE$.", "text_with_entity_marker": "Fetal haemoglobin ([E1]@GENE$[/E1]) level modifies the clinical severity of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Fetal haemoglobin ([GENE]@GENE$[/GENE]) level modifies the clinical severity of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [67, 76], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_idx_in_text_with_typed_entity_marker": [89, 98], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_17", "text": "Moreover, TNF-alpha production was induced by a @GENE$-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.", "text_with_entity_marker": "Moreover, TNF-alpha production was induced by a [E1]@GENE$[/E1]-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Moreover, TNF-alpha production was induced by a [GENE]@GENE$[/GENE]-2 ligand, but a down-regulatory function by the NOD2 ligand, muramyl dipeptide, was impaired significantly in [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [165, 174], "entity_2_idx_in_text_with_entity_marker": [178, 187], "entity_2_idx_in_text_with_typed_entity_marker": [187, 196], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_18", "text": "@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and @DISEASE$, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_entity_marker": "[E1]@GENE$[/E1] interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and [E2]@DISEASE$[/E2], and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] interacts directly with the malate shuttle system, which has been shown to be altered in schizophrenia and [DISEASE]@DISEASE$[/DISEASE], and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [114, 123], "entity_2_idx_in_text_with_entity_marker": [127, 136], "entity_2_idx_in_text_with_typed_entity_marker": [136, 145], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_19", "text": "This review discusses the role of @GENE$ from normal function and its dysfunction in pre-cancerous lesions and @DISEASE$.", "text_with_entity_marker": "This review discusses the role of [E1]@GENE$[/E1] from normal function and its dysfunction in pre-cancerous lesions and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "This review discusses the role of [GENE]@GENE$[/GENE] from normal function and its dysfunction in pre-cancerous lesions and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [34, 40], "entity_1_idx_in_text_with_entity_marker": [38, 44], "entity_1_idx_in_text_with_typed_entity_marker": [40, 46], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [111, 120], "entity_2_idx_in_text_with_entity_marker": [124, 133], "entity_2_idx_in_text_with_typed_entity_marker": [133, 142], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_20", "text": "Surprisingly, the 602S allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the @GENE$ system as a mechanism of immune evasion.", "text_with_entity_marker": "Surprisingly, the 602S allele is associated with a decreased incidence of [E1]@DISEASE$[/E1], suggesting that Mycobacterium leprae subverts the [E2]@GENE$[/E2] system as a mechanism of immune evasion.", "text_with_typed_entity_marker": "Surprisingly, the 602S allele is associated with a decreased incidence of [DISEASE]@DISEASE$[/DISEASE], suggesting that Mycobacterium leprae subverts the [GENE]@GENE$[/GENE] system as a mechanism of immune evasion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [74, 83], "entity_1_idx_in_text_with_entity_marker": [78, 87], "entity_1_idx_in_text_with_typed_entity_marker": [83, 92], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [135, 141], "entity_2_idx_in_text_with_entity_marker": [148, 154], "entity_2_idx_in_text_with_typed_entity_marker": [160, 166], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_21", "text": "We genotyped the four single-nucleotide polymorphisms (@GENE$, rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms ([E1]@GENE$[/E1], rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms ([GENE]@GENE$[/GENE], rs3118470, ss52580101, and rs11594656) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [136, 145], "entity_2_idx_in_text_with_entity_marker": [149, 158], "entity_2_idx_in_text_with_typed_entity_marker": [158, 167], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_22", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, @GENE$ and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [E1]@GENE$[/E1] and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, [GENE]@GENE$[/GENE] and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [103, 109], "entity_1_idx_in_text_with_entity_marker": [107, 113], "entity_1_idx_in_text_with_typed_entity_marker": [109, 115], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_23", "text": "In @DISEASE$ patients, @GENE$-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, [E2]@GENE$[/E2]-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, [GENE]@GENE$[/GENE]-induced GM-CSF secretion was impaired by both NOD2-dependent and -independent mechanisms.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [23, 29], "entity_2_idx_in_text_with_entity_marker": [36, 42], "entity_2_idx_in_text_with_typed_entity_marker": [48, 54], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_24", "text": "In this study, the G2677T/A polymorphism observed in the @GENE$ gene was not found to be a risk factor for @DISEASE$ or ulcerative colitis.", "text_with_entity_marker": "In this study, the G2677T/A polymorphism observed in the [E1]@GENE$[/E1] gene was not found to be a risk factor for [E2]@DISEASE$[/E2] or ulcerative colitis.", "text_with_typed_entity_marker": "In this study, the G2677T/A polymorphism observed in the [GENE]@GENE$[/GENE] gene was not found to be a risk factor for [DISEASE]@DISEASE$[/DISEASE] or ulcerative colitis.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [57, 63], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_idx_in_text_with_typed_entity_marker": [63, 69], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [107, 116], "entity_2_idx_in_text_with_entity_marker": [120, 129], "entity_2_idx_in_text_with_typed_entity_marker": [129, 138], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_25", "text": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and @GENE$, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [E1]@GENE$[/E1], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and [GENE]@GENE$[/GENE], in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [73, 79], "entity_1_idx_in_text_with_entity_marker": [77, 83], "entity_1_idx_in_text_with_typed_entity_marker": [79, 85], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_26", "text": "However, @GENE$ was only expressed in 55% of patients with @DISEASE$.", "text_with_entity_marker": "However, [E1]@GENE$[/E1] was only expressed in 55% of patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "However, [GENE]@GENE$[/GENE] was only expressed in 55% of patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [9, 15], "entity_1_idx_in_text_with_entity_marker": [13, 19], "entity_1_idx_in_text_with_typed_entity_marker": [15, 21], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [59, 68], "entity_2_idx_in_text_with_entity_marker": [72, 81], "entity_2_idx_in_text_with_typed_entity_marker": [81, 90], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_27", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and @GENE$) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and [E1]@GENE$[/E1]) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, rs13199524, rs12198173 and [GENE]@GENE$[/GENE]) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [118, 124], "entity_1_idx_in_text_with_entity_marker": [122, 128], "entity_1_idx_in_text_with_typed_entity_marker": [124, 130], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [186, 195], "entity_2_idx_in_text_with_entity_marker": [199, 208], "entity_2_idx_in_text_with_typed_entity_marker": [208, 217], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_28", "text": "We conclude that stx genotype is one of the important factors of clinical outcome of @DISEASE$ and that pathogenicity for humans was higher in the @GENE$ genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [E1]@DISEASE$[/E1] and that pathogenicity for humans was higher in the [E2]@GENE$[/E2] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "text_with_typed_entity_marker": "We conclude that stx genotype is one of the important factors of clinical outcome of [DISEASE]@DISEASE$[/DISEASE] and that pathogenicity for humans was higher in the [GENE]@GENE$[/GENE] genotype strains than in the stx2vha genotype strains, as reported previously by other researchers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [147, 153], "entity_2_idx_in_text_with_entity_marker": [160, 166], "entity_2_idx_in_text_with_typed_entity_marker": [172, 178], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_29", "text": "No significant associations were observed for @DISEASE$ (@GENE$: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "text_with_entity_marker": "No significant associations were observed for [E1]@DISEASE$[/E1] ([E2]@GENE$[/E2]: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "text_with_typed_entity_marker": "No significant associations were observed for [DISEASE]@DISEASE$[/DISEASE] ([GENE]@GENE$[/GENE]: pAF = 0.49, OR = 1.02 [0.96-1.10]; rs7538490: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [46, 55], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 64], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [57, 63], "entity_2_idx_in_text_with_entity_marker": [70, 76], "entity_2_idx_in_text_with_typed_entity_marker": [82, 88], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_30", "text": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced @DISEASE$ indicate that patients whose tumors were wild-type, but not mutant, for @GENE$ obtained the most clinical benefit from this combination therapy.", "text_with_entity_marker": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced [E1]@DISEASE$[/E1] indicate that patients whose tumors were wild-type, but not mutant, for [E2]@GENE$[/E2] obtained the most clinical benefit from this combination therapy.", "text_with_typed_entity_marker": "The results of a phase I clinical trial of the topoisomerase I (Topo I) poison CPT-11 followed by the cyclin-dependent kinase inhibitor flavopiridol in patients with advanced [DISEASE]@DISEASE$[/DISEASE] indicate that patients whose tumors were wild-type, but not mutant, for [GENE]@GENE$[/GENE] obtained the most clinical benefit from this combination therapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [175, 184], "entity_1_idx_in_text_with_entity_marker": [179, 188], "entity_1_idx_in_text_with_typed_entity_marker": [184, 193], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [257, 263], "entity_2_idx_in_text_with_entity_marker": [270, 276], "entity_2_idx_in_text_with_typed_entity_marker": [282, 288], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_31", "text": "@GENE$ genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing @DISEASE$ compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "text_with_entity_marker": "[E1]@GENE$[/E1] genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing [E2]@DISEASE$[/E2] compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genotypes CG and variants carrying G allele showed statistical significance and very high risk of developing [DISEASE]@DISEASE$[/DISEASE] compared to wild type [CG vs CC; p<0.001, odds ratio (OR)=15.57, 95% confidence interval (CI)=6.56-36.98, CG+GG vs CC; p<0.001, OR=17.58, 95% CI=7.44-41.58].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [116, 125], "entity_2_idx_in_text_with_entity_marker": [129, 138], "entity_2_idx_in_text_with_typed_entity_marker": [138, 147], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_32", "text": "The @GENE$ in women and T in men at SNP +372 T/C was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The [E1]@GENE$[/E1] in women and T in men at SNP +372 T/C was found to increase [E2]@DISEASE$[/E2] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] in women and T in men at SNP +372 T/C was found to increase [DISEASE]@DISEASE$[/DISEASE] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [71, 80], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_idx_in_text_with_typed_entity_marker": [93, 102], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_33", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes @GENE$ ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes [E2]@GENE$[/E2] ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes [GENE]@GENE$[/GENE] ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [398, 404], "entity_2_idx_in_text_with_entity_marker": [411, 417], "entity_2_idx_in_text_with_typed_entity_marker": [423, 429], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_34", "text": "The HBS1L-MYB intergenic region on chromosome @GENE$ is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome [E1]@GENE$[/E1] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome [GENE]@GENE$[/GENE] is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_35", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the @GENE$ in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the [E1]@GENE$[/E1] in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and rs11594656) of the [GENE]@GENE$[/GENE] in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [111, 117], "entity_1_idx_in_text_with_entity_marker": [115, 121], "entity_1_idx_in_text_with_typed_entity_marker": [117, 123], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_36", "text": "Association between donor @GENE$ and graft survival and the development of @DISEASE$ after lung transplantation.", "text_with_entity_marker": "Association between donor [E1]@GENE$[/E1] and graft survival and the development of [E2]@DISEASE$[/E2] after lung transplantation.", "text_with_typed_entity_marker": "Association between donor [GENE]@GENE$[/GENE] and graft survival and the development of [DISEASE]@DISEASE$[/DISEASE] after lung transplantation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [26, 32], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_idx_in_text_with_typed_entity_marker": [32, 38], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_37", "text": "Replication of the TNFSF4 (@GENE$) promoter region association with @DISEASE$.", "text_with_entity_marker": "Replication of the TNFSF4 ([E1]@GENE$[/E1]) promoter region association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Replication of the TNFSF4 ([GENE]@GENE$[/GENE]) promoter region association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [27, 33], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 39], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [68, 77], "entity_2_idx_in_text_with_entity_marker": [81, 90], "entity_2_idx_in_text_with_typed_entity_marker": [90, 99], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_38", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of VEGF and @GENE$ by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of VEGF and [E2]@GENE$[/E2] by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of VEGF and [GENE]@GENE$[/GENE] by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [96, 102], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_idx_in_text_with_typed_entity_marker": [121, 127], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_39", "text": "Allelic and non-allelic heterogeneities in @DISEASE$ revealed by @GENE$ mutational analysis.", "text_with_entity_marker": "Allelic and non-allelic heterogeneities in [E1]@DISEASE$[/E1] revealed by [E2]@GENE$[/E2] mutational analysis.", "text_with_typed_entity_marker": "Allelic and non-allelic heterogeneities in [DISEASE]@DISEASE$[/DISEASE] revealed by [GENE]@GENE$[/GENE] mutational analysis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [43, 52], "entity_1_idx_in_text_with_entity_marker": [47, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 61], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [65, 71], "entity_2_idx_in_text_with_entity_marker": [78, 84], "entity_2_idx_in_text_with_typed_entity_marker": [90, 96], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_40", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, @GENE$, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, [E2]@GENE$[/E2], RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, [GENE]@GENE$[/GENE], RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [451, 457], "entity_2_idx_in_text_with_entity_marker": [464, 470], "entity_2_idx_in_text_with_typed_entity_marker": [476, 482], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_41", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [E1]@GENE$[/E1] (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([E2]@DISEASE$[/E2]), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [GENE]@GENE$[/GENE] (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([DISEASE]@DISEASE$[/DISEASE]), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [275, 284], "entity_2_idx_in_text_with_entity_marker": [288, 297], "entity_2_idx_in_text_with_typed_entity_marker": [297, 306], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_42", "text": "In this study, the G2677T/A polymorphism observed in the @GENE$ gene was not found to be a risk factor for Crohn's disease or @DISEASE$.", "text_with_entity_marker": "In this study, the G2677T/A polymorphism observed in the [E1]@GENE$[/E1] gene was not found to be a risk factor for Crohn's disease or [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In this study, the G2677T/A polymorphism observed in the [GENE]@GENE$[/GENE] gene was not found to be a risk factor for Crohn's disease or [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [57, 63], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_idx_in_text_with_typed_entity_marker": [63, 69], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [126, 135], "entity_2_idx_in_text_with_entity_marker": [139, 148], "entity_2_idx_in_text_with_typed_entity_marker": [148, 157], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_43", "text": "@DISEASE$ patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of @GENE$ secretion.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of [E2]@GENE$[/E2] secretion.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients have impaired GM-CSF secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of [GENE]@GENE$[/GENE] secretion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [153, 159], "entity_2_idx_in_text_with_entity_marker": [166, 172], "entity_2_idx_in_text_with_typed_entity_marker": [178, 184], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_44", "text": "The @GENE$ in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of @DISEASE$ during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The [E1]@GENE$[/E1] in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [E2]@DISEASE$[/E2] during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] in women and T in men at SNP +372 T/C was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [DISEASE]@DISEASE$[/DISEASE] during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [225, 234], "entity_2_idx_in_text_with_entity_marker": [238, 247], "entity_2_idx_in_text_with_typed_entity_marker": [247, 256], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_45", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (@GENE$; within the Syndecan 2 gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 ([E2]@GENE$[/E2]; within the Syndecan 2 gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 ([GENE]@GENE$[/GENE]; within the Syndecan 2 gene).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [259, 265], "entity_2_idx_in_text_with_entity_marker": [272, 278], "entity_2_idx_in_text_with_typed_entity_marker": [284, 290], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_46", "text": "The commonly deleted region of the @DISEASE$ extends between the genes SH3TC2 (proximal boundary) and @GENE$ (distal boundary) and measures 2.9 Mb.", "text_with_entity_marker": "The commonly deleted region of the [E1]@DISEASE$[/E1] extends between the genes SH3TC2 (proximal boundary) and [E2]@GENE$[/E2] (distal boundary) and measures 2.9 Mb.", "text_with_typed_entity_marker": "The commonly deleted region of the [DISEASE]@DISEASE$[/DISEASE] extends between the genes SH3TC2 (proximal boundary) and [GENE]@GENE$[/GENE] (distal boundary) and measures 2.9 Mb.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [35, 44], "entity_1_idx_in_text_with_entity_marker": [39, 48], "entity_1_idx_in_text_with_typed_entity_marker": [44, 53], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [102, 108], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_idx_in_text_with_typed_entity_marker": [127, 133], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_47", "text": "These observations suggest that IL23R makes a substantial contribution to @DISEASE$ susceptibility, larger than that estimated from the population frequency of the @GENE$ variant.", "text_with_entity_marker": "These observations suggest that IL23R makes a substantial contribution to [E1]@DISEASE$[/E1] susceptibility, larger than that estimated from the population frequency of the [E2]@GENE$[/E2] variant.", "text_with_typed_entity_marker": "These observations suggest that IL23R makes a substantial contribution to [DISEASE]@DISEASE$[/DISEASE] susceptibility, larger than that estimated from the population frequency of the [GENE]@GENE$[/GENE] variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [74, 83], "entity_1_idx_in_text_with_entity_marker": [78, 87], "entity_1_idx_in_text_with_typed_entity_marker": [83, 92], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [164, 170], "entity_2_idx_in_text_with_entity_marker": [177, 183], "entity_2_idx_in_text_with_typed_entity_marker": [189, 195], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_48", "text": "DNA repair gene polymorphisms, such as those of @GENE$ and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to @DISEASE$.", "text_with_entity_marker": "DNA repair gene polymorphisms, such as those of [E1]@GENE$[/E1] and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "DNA repair gene polymorphisms, such as those of [GENE]@GENE$[/GENE] and xeroderma pigmentosum, complementation group D and G (XPD, XPG), contribute to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [138, 147], "entity_2_idx_in_text_with_entity_marker": [151, 160], "entity_2_idx_in_text_with_typed_entity_marker": [160, 169], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_49", "text": "The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract tumor angiogenesis/@DISEASE$.", "text_with_entity_marker": "The interleukin-1 receptor antagonist ([E1]@GENE$[/E1]) cytokine is thought to counteract tumor angiogenesis/[E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The interleukin-1 receptor antagonist ([GENE]@GENE$[/GENE]) cytokine is thought to counteract tumor angiogenesis/[DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [39, 45], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 51], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [100, 109], "entity_2_idx_in_text_with_entity_marker": [113, 122], "entity_2_idx_in_text_with_typed_entity_marker": [122, 131], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_50", "text": "Individual @GENE$ SNPs, rs1048661, rs3825942, and rs2165241, were not associated with @DISEASE$ in the Chinese population.", "text_with_entity_marker": "Individual [E1]@GENE$[/E1] SNPs, rs1048661, rs3825942, and rs2165241, were not associated with [E2]@DISEASE$[/E2] in the Chinese population.", "text_with_typed_entity_marker": "Individual [GENE]@GENE$[/GENE] SNPs, rs1048661, rs3825942, and rs2165241, were not associated with [DISEASE]@DISEASE$[/DISEASE] in the Chinese population.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [11, 17], "entity_1_idx_in_text_with_entity_marker": [15, 21], "entity_1_idx_in_text_with_typed_entity_marker": [17, 23], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_51", "text": "From the Cover: Whole-genome association study identifies @GENE$ as a @DISEASE$ susceptibility gene.", "text_with_entity_marker": "From the Cover: Whole-genome association study identifies [E1]@GENE$[/E1] as a [E2]@DISEASE$[/E2] susceptibility gene.", "text_with_typed_entity_marker": "From the Cover: Whole-genome association study identifies [GENE]@GENE$[/GENE] as a [DISEASE]@DISEASE$[/DISEASE] susceptibility gene.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [58, 64], "entity_1_idx_in_text_with_entity_marker": [62, 68], "entity_1_idx_in_text_with_typed_entity_marker": [64, 70], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_52", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (@GENE$; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 ([E2]@GENE$[/E2]; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 ([GENE]@GENE$[/GENE]; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the Syndecan 2 gene).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [174, 180], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_idx_in_text_with_typed_entity_marker": [199, 205], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_53", "text": "@GENE$ polymorphism in the clock gene NPAS2: a circadian modifier for the risk of @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] polymorphism in the clock gene NPAS2: a circadian modifier for the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] polymorphism in the clock gene NPAS2: a circadian modifier for the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_54", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, @GENE$) are associated with Crohn's disease (@DISEASE$).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [E1]@GENE$[/E1]) are associated with Crohn's disease ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [GENE]@GENE$[/GENE]) are associated with Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [157, 163], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_idx_in_text_with_typed_entity_marker": [163, 169], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [202, 211], "entity_2_idx_in_text_with_entity_marker": [215, 224], "entity_2_idx_in_text_with_typed_entity_marker": [224, 233], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_55", "text": "The @GENE$, which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of @DISEASE$ induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_entity_marker": "The [E1]@GENE$[/E1], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [E2]@DISEASE$[/E2] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE], which is involved in the metabolism of vinblastine and doxorubicin, might be a genetic predictor of the severity of [DISEASE]@DISEASE$[/DISEASE] induced by chemotherapy with methotrexate, vinblastine, doxorubicin and cisplatin.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_56", "text": "The study investigated the possible association of @GENE$ gene and @DISEASE$ in a Han Chinese population.", "text_with_entity_marker": "The study investigated the possible association of [E1]@GENE$[/E1] gene and [E2]@DISEASE$[/E2] in a Han Chinese population.", "text_with_typed_entity_marker": "The study investigated the possible association of [GENE]@GENE$[/GENE] gene and [DISEASE]@DISEASE$[/DISEASE] in a Han Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [51, 57], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_idx_in_text_with_typed_entity_marker": [57, 63], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [67, 76], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_idx_in_text_with_typed_entity_marker": [89, 98], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_57", "text": "Identification and replication of three novel @DISEASE$ common susceptibility gene loci on chromosome @GENE$ using linkage and linkage disequilibrium mapping.", "text_with_entity_marker": "Identification and replication of three novel [E1]@DISEASE$[/E1] common susceptibility gene loci on chromosome [E2]@GENE$[/E2] using linkage and linkage disequilibrium mapping.", "text_with_typed_entity_marker": "Identification and replication of three novel [DISEASE]@DISEASE$[/DISEASE] common susceptibility gene loci on chromosome [GENE]@GENE$[/GENE] using linkage and linkage disequilibrium mapping.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [46, 55], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 64], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [102, 108], "entity_2_idx_in_text_with_entity_marker": [115, 121], "entity_2_idx_in_text_with_typed_entity_marker": [127, 133], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_58", "text": "@GENE$, IL-1R and TNFalpha gene polymorphisms in Iranian patients with @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE], IL-1R and TNFalpha gene polymorphisms in Iranian patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [71, 80], "entity_2_idx_in_text_with_entity_marker": [84, 93], "entity_2_idx_in_text_with_typed_entity_marker": [93, 102], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_59", "text": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with @DISEASE$ and found that @GENE$ carriers produced lower levels of IL-10 when compared with non-carriers.", "text_with_entity_marker": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with [E1]@DISEASE$[/E1] and found that [E2]@GENE$[/E2] carriers produced lower levels of IL-10 when compared with non-carriers.", "text_with_typed_entity_marker": "Finally, we tested IL-10 production in peripheral blood mononuclear cells stimulated with [DISEASE]@DISEASE$[/DISEASE] and found that [GENE]@GENE$[/GENE] carriers produced lower levels of IL-10 when compared with non-carriers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [90, 99], "entity_1_idx_in_text_with_entity_marker": [94, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 108], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [115, 121], "entity_2_idx_in_text_with_entity_marker": [128, 134], "entity_2_idx_in_text_with_typed_entity_marker": [140, 146], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_60", "text": "The association of @GENE$ with @DISEASE$ was replicated in all the sets except Spain.", "text_with_entity_marker": "The association of [E1]@GENE$[/E1] with [E2]@DISEASE$[/E2] was replicated in all the sets except Spain.", "text_with_typed_entity_marker": "The association of [GENE]@GENE$[/GENE] with [DISEASE]@DISEASE$[/DISEASE] was replicated in all the sets except Spain.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [31, 40], "entity_2_idx_in_text_with_entity_marker": [44, 53], "entity_2_idx_in_text_with_typed_entity_marker": [53, 62], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_61", "text": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the @GENE$ carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_entity_marker": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the [E1]@GENE$[/E1] carrier status was associated with [E2]@DISEASE$[/E2] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_typed_entity_marker": "Compared with the epsilon3 homozygotes, neither the epsilon2 nor the [GENE]@GENE$[/GENE] carrier status was associated with [DISEASE]@DISEASE$[/DISEASE] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [111, 120], "entity_2_idx_in_text_with_entity_marker": [124, 133], "entity_2_idx_in_text_with_typed_entity_marker": [133, 142], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_62", "text": "Our results suggested that common genetic variants in @GENE$ may modulate the risk of developing @DISEASE$ in the study population, particularly in non-smokers.", "text_with_entity_marker": "Our results suggested that common genetic variants in [E1]@GENE$[/E1] may modulate the risk of developing [E2]@DISEASE$[/E2] in the study population, particularly in non-smokers.", "text_with_typed_entity_marker": "Our results suggested that common genetic variants in [GENE]@GENE$[/GENE] may modulate the risk of developing [DISEASE]@DISEASE$[/DISEASE] in the study population, particularly in non-smokers.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [54, 60], "entity_1_idx_in_text_with_entity_marker": [58, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 66], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_63", "text": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the @GENE$ gene revealed one SNP and one haplotype associated with the phenotype of @DISEASE$ in the CVCR sample.", "text_with_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [E1]@GENE$[/E1] gene revealed one SNP and one haplotype associated with the phenotype of [E2]@DISEASE$[/E2] in the CVCR sample.", "text_with_typed_entity_marker": "Subsequent analysis of individual SNPs in strong linkage disequilibrium with the [GENE]@GENE$[/GENE] gene revealed one SNP and one haplotype associated with the phenotype of [DISEASE]@DISEASE$[/DISEASE] in the CVCR sample.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [81, 87], "entity_1_idx_in_text_with_entity_marker": [85, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 93], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [161, 170], "entity_2_idx_in_text_with_entity_marker": [174, 183], "entity_2_idx_in_text_with_typed_entity_marker": [183, 192], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_64", "text": "No association of @GENE$ or XPD Lys751Gln and @DISEASE$ was found.", "text_with_entity_marker": "No association of [E1]@GENE$[/E1] or XPD Lys751Gln and [E2]@DISEASE$[/E2] was found.", "text_with_typed_entity_marker": "No association of [GENE]@GENE$[/GENE] or XPD Lys751Gln and [DISEASE]@DISEASE$[/DISEASE] was found.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [46, 55], "entity_2_idx_in_text_with_entity_marker": [59, 68], "entity_2_idx_in_text_with_typed_entity_marker": [68, 77], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_65", "text": "In contrast, the @GENE$ genotype was not associated with @DISEASE$ viremia or with the HCV core antigen level.", "text_with_entity_marker": "In contrast, the [E1]@GENE$[/E1] genotype was not associated with [E2]@DISEASE$[/E2] viremia or with the HCV core antigen level.", "text_with_typed_entity_marker": "In contrast, the [GENE]@GENE$[/GENE] genotype was not associated with [DISEASE]@DISEASE$[/DISEASE] viremia or with the HCV core antigen level.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [17, 23], "entity_1_idx_in_text_with_entity_marker": [21, 27], "entity_1_idx_in_text_with_typed_entity_marker": [23, 29], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [57, 66], "entity_2_idx_in_text_with_entity_marker": [70, 79], "entity_2_idx_in_text_with_typed_entity_marker": [79, 88], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_66", "text": "The C-allele of PKLR rs3020781 and the T-allele of @GENE$ rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The C-allele of PKLR rs3020781 and the T-allele of [E1]@GENE$[/E1] rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The C-allele of PKLR rs3020781 and the T-allele of [GENE]@GENE$[/GENE] rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [51, 57], "entity_1_idx_in_text_with_entity_marker": [55, 61], "entity_1_idx_in_text_with_typed_entity_marker": [57, 63], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [108, 117], "entity_2_idx_in_text_with_entity_marker": [121, 130], "entity_2_idx_in_text_with_typed_entity_marker": [130, 139], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_67", "text": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on @GENE$ levels in @DISEASE$ (CKD) patients before and after a successful kidney transplantation.", "text_with_entity_marker": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on [E1]@GENE$[/E1] levels in [E2]@DISEASE$[/E2] (CKD) patients before and after a successful kidney transplantation.", "text_with_typed_entity_marker": "We sought to evaluate 2 single-nucleotide polymorphisms (SNPs) in the C-reactive protein (CRP) gene promoter region for their effects on [GENE]@GENE$[/GENE] levels in [DISEASE]@DISEASE$[/DISEASE] (CKD) patients before and after a successful kidney transplantation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [137, 143], "entity_1_idx_in_text_with_entity_marker": [141, 147], "entity_1_idx_in_text_with_typed_entity_marker": [143, 149], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [154, 163], "entity_2_idx_in_text_with_entity_marker": [167, 176], "entity_2_idx_in_text_with_typed_entity_marker": [176, 185], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_68", "text": "The genetic contribution of @GENE$ gene to @DISEASE$ susceptibility was investigated using an integrated population genetic and molecular analysis.", "text_with_entity_marker": "The genetic contribution of [E1]@GENE$[/E1] gene to [E2]@DISEASE$[/E2] susceptibility was investigated using an integrated population genetic and molecular analysis.", "text_with_typed_entity_marker": "The genetic contribution of [GENE]@GENE$[/GENE] gene to [DISEASE]@DISEASE$[/DISEASE] susceptibility was investigated using an integrated population genetic and molecular analysis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [43, 52], "entity_2_idx_in_text_with_entity_marker": [56, 65], "entity_2_idx_in_text_with_typed_entity_marker": [65, 74], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_69", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), @GENE$, within the interleukin-23 receptor (IL23R) locus and @DISEASE$ (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [E1]@GENE$[/E1], within the interleukin-23 receptor (IL23R) locus and [E2]@DISEASE$[/E2] (CD) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [GENE]@GENE$[/GENE], within the interleukin-23 receptor (IL23R) locus and [DISEASE]@DISEASE$[/DISEASE] (CD) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [84, 90], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_idx_in_text_with_typed_entity_marker": [90, 96], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [145, 154], "entity_2_idx_in_text_with_entity_marker": [158, 167], "entity_2_idx_in_text_with_typed_entity_marker": [167, 176], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_70", "text": "@GENE$ (Abeta) levels are elevated in the brain of @DISEASE$ patients.", "text_with_entity_marker": "[E1]@GENE$[/E1] (Abeta) levels are elevated in the brain of [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (Abeta) levels are elevated in the brain of [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_71", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and @GENE$) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and [E1]@GENE$[/E1]) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, ss52580101, and [GENE]@GENE$[/GENE]) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [92, 98], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_idx_in_text_with_typed_entity_marker": [98, 104], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_72", "text": "The @GENE$ polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated @DISEASE$ in dialysis patients.", "text_with_entity_marker": "The [E1]@GENE$[/E1] polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated [E2]@DISEASE$[/E2] in dialysis patients.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] polymorphism (Thr256Ser) is associated with reduced fetuin levels and accelerated [DISEASE]@DISEASE$[/DISEASE] in dialysis patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [93, 102], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_idx_in_text_with_typed_entity_marker": [115, 124], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_73", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, @GENE$, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, [E2]@GENE$[/E2], ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, [GENE]@GENE$[/GENE], ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [617, 623], "entity_2_idx_in_text_with_entity_marker": [630, 636], "entity_2_idx_in_text_with_typed_entity_marker": [642, 648], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_74", "text": "@GENE$ was expressed in 60% and VEGFR-1 in 39% of @DISEASE$ specimens.", "text_with_entity_marker": "[E1]@GENE$[/E1] was expressed in 60% and VEGFR-1 in 39% of [E2]@DISEASE$[/E2] specimens.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] was expressed in 60% and VEGFR-1 in 39% of [DISEASE]@DISEASE$[/DISEASE] specimens.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [50, 59], "entity_2_idx_in_text_with_entity_marker": [63, 72], "entity_2_idx_in_text_with_typed_entity_marker": [72, 81], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_75", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and @GENE$ (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [E1]@GENE$[/E1] (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and [GENE]@GENE$[/GENE] (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_76", "text": "Toll-like receptor-induced @GENE$ secretion is impaired in @DISEASE$ by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_entity_marker": "Toll-like receptor-induced [E1]@GENE$[/E1] secretion is impaired in [E2]@DISEASE$[/E2] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_typed_entity_marker": "Toll-like receptor-induced [GENE]@GENE$[/GENE] secretion is impaired in [DISEASE]@DISEASE$[/DISEASE] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [27, 33], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 39], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [59, 68], "entity_2_idx_in_text_with_entity_marker": [72, 81], "entity_2_idx_in_text_with_typed_entity_marker": [81, 90], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_77", "text": "The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the @GENE$ gene may be associated with protection from HIV-1 @DISEASE$, while the 1604G allele may have a weak association with the clinical course of infection in DU.", "text_with_entity_marker": "The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the [E1]@GENE$[/E1] gene may be associated with protection from HIV-1 [E2]@DISEASE$[/E2], while the 1604G allele may have a weak association with the clinical course of infection in DU.", "text_with_typed_entity_marker": "The results obtained in this study suggest that the A1650G polymorphism in the regulatory region of the [GENE]@GENE$[/GENE] gene may be associated with protection from HIV-1 [DISEASE]@DISEASE$[/DISEASE], while the 1604G allele may have a weak association with the clinical course of infection in DU.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [104, 110], "entity_1_idx_in_text_with_entity_marker": [108, 114], "entity_1_idx_in_text_with_typed_entity_marker": [110, 116], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [161, 170], "entity_2_idx_in_text_with_entity_marker": [174, 183], "entity_2_idx_in_text_with_typed_entity_marker": [183, 192], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_78", "text": "Hypomorphic @GENE$/NPHP6 mutations result in @DISEASE$ caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "text_with_entity_marker": "Hypomorphic [E1]@GENE$[/E1]/NPHP6 mutations result in [E2]@DISEASE$[/E2] caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "text_with_typed_entity_marker": "Hypomorphic [GENE]@GENE$[/GENE]/NPHP6 mutations result in [DISEASE]@DISEASE$[/DISEASE] caused by the selective loss of G proteins in cilia of olfactory sensory neurons.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [12, 18], "entity_1_idx_in_text_with_entity_marker": [16, 22], "entity_1_idx_in_text_with_typed_entity_marker": [18, 24], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [45, 54], "entity_2_idx_in_text_with_entity_marker": [58, 67], "entity_2_idx_in_text_with_typed_entity_marker": [67, 76], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_79", "text": "A total of 180 patients with @DISEASE$ were categorized as high @GENE$ producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).", "text_with_entity_marker": "A total of 180 patients with [E1]@DISEASE$[/E1] were categorized as high [E2]@GENE$[/E2] producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).", "text_with_typed_entity_marker": "A total of 180 patients with [DISEASE]@DISEASE$[/DISEASE] were categorized as high [GENE]@GENE$[/GENE] producers if they were carriers of at least one of the rs4251961 T/T or rs579543 T/T genotypes (T/T carriers).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [29, 38], "entity_1_idx_in_text_with_entity_marker": [33, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 47], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [64, 70], "entity_2_idx_in_text_with_entity_marker": [77, 83], "entity_2_idx_in_text_with_typed_entity_marker": [89, 95], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_80", "text": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular @GENE$ and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular [E1]@GENE$[/E1] and L1007fsinsC, are involved with [E2]@DISEASE$[/E2] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_typed_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular [GENE]@GENE$[/GENE] and L1007fsinsC, are involved with [DISEASE]@DISEASE$[/DISEASE] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [123, 129], "entity_1_idx_in_text_with_entity_marker": [127, 133], "entity_1_idx_in_text_with_typed_entity_marker": [129, 135], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [165, 174], "entity_2_idx_in_text_with_entity_marker": [178, 187], "entity_2_idx_in_text_with_typed_entity_marker": [187, 196], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_81", "text": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their @GENE$ expression probably because of their saturation of GHRH signaling.", "text_with_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [E1]@DISEASE$[/E1] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their [E2]@GENE$[/E2] expression probably because of their saturation of GHRH signaling.", "text_with_typed_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [DISEASE]@DISEASE$[/DISEASE] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their [GENE]@GENE$[/GENE] expression probably because of their saturation of GHRH signaling.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [78, 87], "entity_1_idx_in_text_with_entity_marker": [82, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 96], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [174, 180], "entity_2_idx_in_text_with_entity_marker": [187, 193], "entity_2_idx_in_text_with_typed_entity_marker": [199, 205], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_82", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, @GENE$, ss52580101, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [E1]@GENE$[/E1], ss52580101, and rs11594656) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, [GENE]@GENE$[/GENE], ss52580101, and rs11594656) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_83", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes @GENE$ (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes [E2]@GENE$[/E2] (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes [GENE]@GENE$[/GENE] (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [267, 273], "entity_2_idx_in_text_with_entity_marker": [280, 286], "entity_2_idx_in_text_with_typed_entity_marker": [292, 298], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_84", "text": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), @GENE$ (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.", "text_with_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [E1]@GENE$[/E1] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "On the other hand the frequency of IL-1alpha TT -889 genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), [GENE]@GENE$[/GENE] (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [138, 144], "entity_1_idx_in_text_with_entity_marker": [142, 148], "entity_1_idx_in_text_with_typed_entity_marker": [144, 150], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [390, 399], "entity_2_idx_in_text_with_entity_marker": [403, 412], "entity_2_idx_in_text_with_typed_entity_marker": [412, 421], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_85", "text": "Genetic alterations within the @GENE$ gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all @DISEASE$.", "text_with_entity_marker": "Genetic alterations within the [E1]@GENE$[/E1] gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Genetic alterations within the [GENE]@GENE$[/GENE] gene have been shown to have a direct correlation with cancer development and have been shown to occur in nearly 50% of all [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [162, 171], "entity_2_idx_in_text_with_entity_marker": [175, 184], "entity_2_idx_in_text_with_typed_entity_marker": [184, 193], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_86", "text": "Genetic variations in @GENE$ were identified and genotyped in 295 unrelated patients with @DISEASE$ and 180 control subjects.", "text_with_entity_marker": "Genetic variations in [E1]@GENE$[/E1] were identified and genotyped in 295 unrelated patients with [E2]@DISEASE$[/E2] and 180 control subjects.", "text_with_typed_entity_marker": "Genetic variations in [GENE]@GENE$[/GENE] were identified and genotyped in 295 unrelated patients with [DISEASE]@DISEASE$[/DISEASE] and 180 control subjects.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [90, 99], "entity_2_idx_in_text_with_entity_marker": [103, 112], "entity_2_idx_in_text_with_typed_entity_marker": [112, 121], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_87", "text": "These results strongly suggest that the g.-247C/T polymorphism in the @GENE$ promoter region is associated with the risk of @DISEASE$.", "text_with_entity_marker": "These results strongly suggest that the g.-247C/T polymorphism in the [E1]@GENE$[/E1] promoter region is associated with the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results strongly suggest that the g.-247C/T polymorphism in the [GENE]@GENE$[/GENE] promoter region is associated with the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [70, 76], "entity_1_idx_in_text_with_entity_marker": [74, 80], "entity_1_idx_in_text_with_typed_entity_marker": [76, 82], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [124, 133], "entity_2_idx_in_text_with_entity_marker": [137, 146], "entity_2_idx_in_text_with_typed_entity_marker": [146, 155], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_88", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in @GENE$ and GPx2 double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [E1]@DISEASE$[/E1] in [E2]@GENE$[/E2] and GPx2 double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [DISEASE]@DISEASE$[/DISEASE] in [GENE]@GENE$[/GENE] and GPx2 double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [106, 115], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_idx_in_text_with_typed_entity_marker": [115, 124], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [119, 125], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_idx_in_text_with_typed_entity_marker": [144, 150], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_89", "text": "The @GENE$ pathway plays a pivotal role in the development of @DISEASE$ seen in the inflammatory bowel diseases.", "text_with_entity_marker": "The [E1]@GENE$[/E1] pathway plays a pivotal role in the development of [E2]@DISEASE$[/E2] seen in the inflammatory bowel diseases.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] pathway plays a pivotal role in the development of [DISEASE]@DISEASE$[/DISEASE] seen in the inflammatory bowel diseases.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [62, 71], "entity_2_idx_in_text_with_entity_marker": [75, 84], "entity_2_idx_in_text_with_typed_entity_marker": [84, 93], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_90", "text": "Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (@DISEASE$) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma ([E2]@DISEASE$[/E2]) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma ([DISEASE]@DISEASE$[/DISEASE]) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [155, 164], "entity_2_idx_in_text_with_entity_marker": [168, 177], "entity_2_idx_in_text_with_typed_entity_marker": [177, 186], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_91", "text": "@GENE$ is a calcification inhibitor and correlates negatively with increased @DISEASE$ in dialysis patients.", "text_with_entity_marker": "[E1]@GENE$[/E1] is a calcification inhibitor and correlates negatively with increased [E2]@DISEASE$[/E2] in dialysis patients.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] is a calcification inhibitor and correlates negatively with increased [DISEASE]@DISEASE$[/DISEASE] in dialysis patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_92", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), @GENE$ Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), [E2]@GENE$[/E2] Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), [GENE]@GENE$[/GENE] Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [312, 318], "entity_2_idx_in_text_with_entity_marker": [325, 331], "entity_2_idx_in_text_with_typed_entity_marker": [337, 343], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_93", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, @GENE$), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, [E2]@GENE$[/E2]), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, [GENE]@GENE$[/GENE]), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [301, 307], "entity_2_idx_in_text_with_entity_marker": [314, 320], "entity_2_idx_in_text_with_typed_entity_marker": [326, 332], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_94", "text": "Individual LOXL1 SNPs, @GENE$, rs3825942, and rs2165241, were not associated with @DISEASE$ in the Chinese population.", "text_with_entity_marker": "Individual LOXL1 SNPs, [E1]@GENE$[/E1], rs3825942, and rs2165241, were not associated with [E2]@DISEASE$[/E2] in the Chinese population.", "text_with_typed_entity_marker": "Individual LOXL1 SNPs, [GENE]@GENE$[/GENE], rs3825942, and rs2165241, were not associated with [DISEASE]@DISEASE$[/DISEASE] in the Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_95", "text": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., @GENE$) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [E1]@GENE$[/E1]) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP rs491347 and its strongly associated SNPs (e.g., [GENE]@GENE$[/GENE]) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [105, 114], "entity_2_idx_in_text_with_entity_marker": [118, 127], "entity_2_idx_in_text_with_typed_entity_marker": [127, 136], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_96", "text": "The TIMP-1 genotype TT in women and T in men at @GENE$ was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of @DISEASE$ during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The TIMP-1 genotype TT in women and T in men at [E1]@GENE$[/E1] was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [E2]@DISEASE$[/E2] during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The TIMP-1 genotype TT in women and T in men at [GENE]@GENE$[/GENE] was found to increase CD susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of [DISEASE]@DISEASE$[/DISEASE] during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [231, 240], "entity_2_idx_in_text_with_entity_marker": [244, 253], "entity_2_idx_in_text_with_typed_entity_marker": [253, 262], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_97", "text": "Lack of association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between PKLR rs3020781 and [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [58, 67], "entity_2_idx_in_text_with_entity_marker": [71, 80], "entity_2_idx_in_text_with_typed_entity_marker": [80, 89], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_98", "text": "The interleukin-1 receptor antagonist (@GENE$) cytokine is thought to counteract @DISEASE$/metastasis.", "text_with_entity_marker": "The interleukin-1 receptor antagonist ([E1]@GENE$[/E1]) cytokine is thought to counteract [E2]@DISEASE$[/E2]/metastasis.", "text_with_typed_entity_marker": "The interleukin-1 receptor antagonist ([GENE]@GENE$[/GENE]) cytokine is thought to counteract [DISEASE]@DISEASE$[/DISEASE]/metastasis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [39, 45], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 51], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [81, 90], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_idx_in_text_with_typed_entity_marker": [103, 112], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_99", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with @DISEASE$ and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE] and Meckel syndromes, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_100", "text": "Lack of association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and type 2 diabetes, [E2]@DISEASE$[/E2], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and type 2 diabetes, [DISEASE]@DISEASE$[/DISEASE], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_101", "text": "As such, @GENE$ gene confer a similar magnitude of risk of @DISEASE$ to children as for their adult counterparts.", "text_with_entity_marker": "As such, [E1]@GENE$[/E1] gene confer a similar magnitude of risk of [E2]@DISEASE$[/E2] to children as for their adult counterparts.", "text_with_typed_entity_marker": "As such, [GENE]@GENE$[/GENE] gene confer a similar magnitude of risk of [DISEASE]@DISEASE$[/DISEASE] to children as for their adult counterparts.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [9, 15], "entity_1_idx_in_text_with_entity_marker": [13, 19], "entity_1_idx_in_text_with_typed_entity_marker": [15, 21], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [59, 68], "entity_2_idx_in_text_with_entity_marker": [72, 81], "entity_2_idx_in_text_with_typed_entity_marker": [81, 90], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_102", "text": "@DISEASE$ patients with NOD2 mutations were able to secrete TNF-alpha, but not @GENE$, upon stimulation with NOD2 and TLR-7 ligands.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients with NOD2 mutations were able to secrete TNF-alpha, but not [E2]@GENE$[/E2], upon stimulation with NOD2 and TLR-7 ligands.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients with NOD2 mutations were able to secrete TNF-alpha, but not [GENE]@GENE$[/GENE], upon stimulation with NOD2 and TLR-7 ligands.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [79, 85], "entity_2_idx_in_text_with_entity_marker": [92, 98], "entity_2_idx_in_text_with_typed_entity_marker": [104, 110], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_103", "text": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for @GENE$ (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.", "text_with_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for [E1]@GENE$[/E1] (uncorrected p = .004) to the affected [E2]@DISEASE$[/E2] offspring were observed.", "text_with_typed_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for [GENE]@GENE$[/GENE] (uncorrected p = .004) to the affected [DISEASE]@DISEASE$[/DISEASE] offspring were observed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [200, 206], "entity_1_idx_in_text_with_entity_marker": [204, 210], "entity_1_idx_in_text_with_typed_entity_marker": [206, 212], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_104", "text": "In the case-control association analysis, the @GENE$ polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the [E1]@GENE$[/E1] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the [GENE]@GENE$[/GENE] polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [230, 239], "entity_2_idx_in_text_with_entity_marker": [243, 252], "entity_2_idx_in_text_with_typed_entity_marker": [252, 261], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_105", "text": "However, the majority of @DISEASE$ cells have deregulation of the @GENE$/beta-catenin pathway.", "text_with_entity_marker": "However, the majority of [E1]@DISEASE$[/E1] cells have deregulation of the [E2]@GENE$[/E2]/beta-catenin pathway.", "text_with_typed_entity_marker": "However, the majority of [DISEASE]@DISEASE$[/DISEASE] cells have deregulation of the [GENE]@GENE$[/GENE]/beta-catenin pathway.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [25, 34], "entity_1_idx_in_text_with_entity_marker": [29, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 43], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [66, 72], "entity_2_idx_in_text_with_entity_marker": [79, 85], "entity_2_idx_in_text_with_typed_entity_marker": [91, 97], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_106", "text": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in @DISEASE$ by @GENE$-dependent and -independent pathways.", "text_with_entity_marker": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [E1]@DISEASE$[/E1] by [E2]@GENE$[/E2]-dependent and -independent pathways.", "text_with_typed_entity_marker": "Toll-like receptor-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [DISEASE]@DISEASE$[/DISEASE] by [GENE]@GENE$[/GENE]-dependent and -independent pathways.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [101, 110], "entity_1_idx_in_text_with_entity_marker": [105, 114], "entity_1_idx_in_text_with_typed_entity_marker": [110, 119], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [114, 120], "entity_2_idx_in_text_with_entity_marker": [127, 133], "entity_2_idx_in_text_with_typed_entity_marker": [139, 145], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_107", "text": "These results suggest that combination of HDACi with adenoviral @GENE$ gene therapy may be a new therapeutic approach for the treatment of @DISEASE$ that warrants further investigation.", "text_with_entity_marker": "These results suggest that combination of HDACi with adenoviral [E1]@GENE$[/E1] gene therapy may be a new therapeutic approach for the treatment of [E2]@DISEASE$[/E2] that warrants further investigation.", "text_with_typed_entity_marker": "These results suggest that combination of HDACi with adenoviral [GENE]@GENE$[/GENE] gene therapy may be a new therapeutic approach for the treatment of [DISEASE]@DISEASE$[/DISEASE] that warrants further investigation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [64, 70], "entity_1_idx_in_text_with_entity_marker": [68, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 76], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_108", "text": "@GENE$ mRNA was expressed in 100% of the controls and @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] mRNA was expressed in 100% of the controls and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] mRNA was expressed in 100% of the controls and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [54, 63], "entity_2_idx_in_text_with_entity_marker": [67, 76], "entity_2_idx_in_text_with_typed_entity_marker": [76, 85], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_109", "text": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and @GENE$ affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_entity_marker": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and [E1]@GENE$[/E1] affect [E2]@DISEASE$[/E2] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_typed_entity_marker": "Allelic composition at the examined SNPs in genes coding for TIMP-1 and [GENE]@GENE$[/GENE] affect [DISEASE]@DISEASE$[/DISEASE] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [72, 78], "entity_1_idx_in_text_with_entity_marker": [76, 82], "entity_1_idx_in_text_with_typed_entity_marker": [78, 84], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_110", "text": "Thus, @GENE$ may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of @DISEASE$.", "text_with_entity_marker": "Thus, [E1]@GENE$[/E1] may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Thus, [GENE]@GENE$[/GENE] may prevent undue responses to inflammatory stimuli and, in consequence, inflammation-driven initiation of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [6, 12], "entity_1_idx_in_text_with_entity_marker": [10, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 18], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_111", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [E1]@GENE$[/E1] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([E2]@DISEASE$[/E2]), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [GENE]@GENE$[/GENE] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of inflammatory bowel diseases ([DISEASE]@DISEASE$[/DISEASE]), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [143, 149], "entity_1_idx_in_text_with_entity_marker": [147, 153], "entity_1_idx_in_text_with_typed_entity_marker": [149, 155], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [257, 266], "entity_2_idx_in_text_with_entity_marker": [270, 279], "entity_2_idx_in_text_with_typed_entity_marker": [279, 288], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_112", "text": "Estrogen-dependent downregulation of @GENE$ gene expression in @DISEASE$ cells is mediated via a 3' distal element.", "text_with_entity_marker": "Estrogen-dependent downregulation of [E1]@GENE$[/E1] gene expression in [E2]@DISEASE$[/E2] cells is mediated via a 3' distal element.", "text_with_typed_entity_marker": "Estrogen-dependent downregulation of [GENE]@GENE$[/GENE] gene expression in [DISEASE]@DISEASE$[/DISEASE] cells is mediated via a 3' distal element.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [37, 43], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_idx_in_text_with_typed_entity_marker": [43, 49], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [63, 72], "entity_2_idx_in_text_with_entity_marker": [76, 85], "entity_2_idx_in_text_with_typed_entity_marker": [85, 94], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_113", "text": "Overall and relapse-free survival in oropharyngeal and @DISEASE$ are associated with genotypes of @GENE$ gene.", "text_with_entity_marker": "Overall and relapse-free survival in oropharyngeal and [E1]@DISEASE$[/E1] are associated with genotypes of [E2]@GENE$[/E2] gene.", "text_with_typed_entity_marker": "Overall and relapse-free survival in oropharyngeal and [DISEASE]@DISEASE$[/DISEASE] are associated with genotypes of [GENE]@GENE$[/GENE] gene.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [55, 64], "entity_1_idx_in_text_with_entity_marker": [59, 68], "entity_1_idx_in_text_with_typed_entity_marker": [64, 73], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [98, 104], "entity_2_idx_in_text_with_entity_marker": [111, 117], "entity_2_idx_in_text_with_typed_entity_marker": [123, 129], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_114", "text": "@GENE$ (ApoE) polymorphism influences lipid metabolism, but its association with @DISEASE$ is controversial.", "text_with_entity_marker": "[E1]@GENE$[/E1] (ApoE) polymorphism influences lipid metabolism, but its association with [E2]@DISEASE$[/E2] is controversial.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (ApoE) polymorphism influences lipid metabolism, but its association with [DISEASE]@DISEASE$[/DISEASE] is controversial.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [81, 90], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_idx_in_text_with_typed_entity_marker": [103, 112], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_115", "text": "These observations suggest that @GENE$ makes a substantial contribution to @DISEASE$ susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "text_with_entity_marker": "These observations suggest that [E1]@GENE$[/E1] makes a substantial contribution to [E2]@DISEASE$[/E2] susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "text_with_typed_entity_marker": "These observations suggest that [GENE]@GENE$[/GENE] makes a substantial contribution to [DISEASE]@DISEASE$[/DISEASE] susceptibility, larger than that estimated from the population frequency of the R381Q variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [32, 38], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 44], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_116", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (@GENE$, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV ([E2]@GENE$[/E2], PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV ([GENE]@GENE$[/GENE], PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [274, 280], "entity_2_idx_in_text_with_entity_marker": [287, 293], "entity_2_idx_in_text_with_typed_entity_marker": [299, 305], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_117", "text": "Role of @GENE$ gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of @DISEASE$.", "text_with_entity_marker": "Role of [E1]@GENE$[/E1] gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Role of [GENE]@GENE$[/GENE] gene in the development of pancreatic cancer and efficiency of inhibitors of this gene in the treatment of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [8, 14], "entity_1_idx_in_text_with_entity_marker": [12, 18], "entity_1_idx_in_text_with_typed_entity_marker": [14, 20], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [122, 131], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_idx_in_text_with_typed_entity_marker": [144, 153], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_118", "text": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of @GENE$ showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of [E1]@GENE$[/E1] showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, rs3826047 and rs3743500, in order) in the 5'-upstream of [GENE]@GENE$[/GENE] showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [116, 122], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_idx_in_text_with_typed_entity_marker": [122, 128], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [330, 339], "entity_2_idx_in_text_with_entity_marker": [343, 352], "entity_2_idx_in_text_with_typed_entity_marker": [352, 361], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_119", "text": "The expression of @GENE$ (GHRHR) is regulated by GHRH, both of which are known to be expressed in human @DISEASE$ cells.", "text_with_entity_marker": "The expression of [E1]@GENE$[/E1] (GHRHR) is regulated by GHRH, both of which are known to be expressed in human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "The expression of [GENE]@GENE$[/GENE] (GHRHR) is regulated by GHRH, both of which are known to be expressed in human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_120", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, @GENE$, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, [E2]@GENE$[/E2], TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, [GENE]@GENE$[/GENE], TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [290, 296], "entity_2_idx_in_text_with_entity_marker": [303, 309], "entity_2_idx_in_text_with_typed_entity_marker": [315, 321], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_121", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, @GENE$) are associated with @DISEASE$ (CD).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [E1]@GENE$[/E1]) are associated with [E2]@DISEASE$[/E2] (CD).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (NOD2, [GENE]@GENE$[/GENE]) are associated with [DISEASE]@DISEASE$[/DISEASE] (CD).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [157, 163], "entity_1_idx_in_text_with_entity_marker": [161, 167], "entity_1_idx_in_text_with_typed_entity_marker": [163, 169], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_122", "text": "The C-allele of @GENE$ rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The C-allele of [E1]@GENE$[/E1] rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The C-allele of [GENE]@GENE$[/GENE] rs3020781 and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [16, 22], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_idx_in_text_with_typed_entity_marker": [22, 28], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [110, 119], "entity_2_idx_in_text_with_entity_marker": [123, 132], "entity_2_idx_in_text_with_typed_entity_marker": [132, 141], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_123", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both @DISEASE$ and manic disorders, including schizophrenia and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both [E2]@DISEASE$[/E2] and manic disorders, including schizophrenia and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both [DISEASE]@DISEASE$[/DISEASE] and manic disorders, including schizophrenia and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_124", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (@GENE$; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 ([E1]@GENE$[/E1]; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 ([GENE]@GENE$[/GENE]; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [162, 168], "entity_1_idx_in_text_with_entity_marker": [166, 172], "entity_1_idx_in_text_with_typed_entity_marker": [168, 174], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [230, 239], "entity_2_idx_in_text_with_entity_marker": [243, 252], "entity_2_idx_in_text_with_typed_entity_marker": [252, 261], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_125", "text": "Previous studies of the @DISEASE$ have shown that HLA and @GENE$ genetic variants influence disease progression and early viral load.", "text_with_entity_marker": "Previous studies of the [E1]@DISEASE$[/E1] have shown that HLA and [E2]@GENE$[/E2] genetic variants influence disease progression and early viral load.", "text_with_typed_entity_marker": "Previous studies of the [DISEASE]@DISEASE$[/DISEASE] have shown that HLA and [GENE]@GENE$[/GENE] genetic variants influence disease progression and early viral load.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [24, 33], "entity_1_idx_in_text_with_entity_marker": [28, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 42], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [58, 64], "entity_2_idx_in_text_with_entity_marker": [71, 77], "entity_2_idx_in_text_with_typed_entity_marker": [83, 89], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_126", "text": "IL-1, IL-1R and @GENE$ in Iranian patients with @DISEASE$.", "text_with_entity_marker": "IL-1, IL-1R and [E1]@GENE$[/E1] in Iranian patients with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "IL-1, IL-1R and [GENE]@GENE$[/GENE] in Iranian patients with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [16, 22], "entity_1_idx_in_text_with_entity_marker": [20, 26], "entity_1_idx_in_text_with_typed_entity_marker": [22, 28], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_127", "text": "The @GENE$ intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] intergenic region on chromosome 6q23 is a quantitative trait locus controlling fetal haemoglobin level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [129, 138], "entity_2_idx_in_text_with_entity_marker": [142, 151], "entity_2_idx_in_text_with_typed_entity_marker": [151, 160], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_128", "text": "In the independent trio samples, @GENE$ and rs677221-G consistently showed significant under-transmission to @DISEASE$ offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_entity_marker": "In the independent trio samples, [E1]@GENE$[/E1] and rs677221-G consistently showed significant under-transmission to [E2]@DISEASE$[/E2] offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_typed_entity_marker": "In the independent trio samples, [GENE]@GENE$[/GENE] and rs677221-G consistently showed significant under-transmission to [DISEASE]@DISEASE$[/DISEASE] offspring (unadjusted p = .003 and p = .004, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [33, 39], "entity_1_idx_in_text_with_entity_marker": [37, 43], "entity_1_idx_in_text_with_typed_entity_marker": [39, 45], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [109, 118], "entity_2_idx_in_text_with_entity_marker": [122, 131], "entity_2_idx_in_text_with_typed_entity_marker": [131, 140], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_129", "text": "Similarly, @GENE$ (AA) reduced the risk of cervical or @DISEASE$.", "text_with_entity_marker": "Similarly, [E1]@GENE$[/E1] (AA) reduced the risk of cervical or [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Similarly, [GENE]@GENE$[/GENE] (AA) reduced the risk of cervical or [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [11, 17], "entity_1_idx_in_text_with_entity_marker": [15, 21], "entity_1_idx_in_text_with_typed_entity_marker": [17, 23], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [55, 64], "entity_2_idx_in_text_with_entity_marker": [68, 77], "entity_2_idx_in_text_with_typed_entity_marker": [77, 86], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_130", "text": "The implicated @GENE$ have not been associated with primary open-angle glaucoma (@DISEASE$).", "text_with_entity_marker": "The implicated [E1]@GENE$[/E1] have not been associated with primary open-angle glaucoma ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "The implicated [GENE]@GENE$[/GENE] have not been associated with primary open-angle glaucoma ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [15, 21], "entity_1_idx_in_text_with_entity_marker": [19, 25], "entity_1_idx_in_text_with_typed_entity_marker": [21, 27], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [81, 90], "entity_2_idx_in_text_with_entity_marker": [94, 103], "entity_2_idx_in_text_with_typed_entity_marker": [103, 112], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_131", "text": "Our work supported @GENE$ genetic variants as possible susceptibility factors for @DISEASE$ and fractures in humans.", "text_with_entity_marker": "Our work supported [E1]@GENE$[/E1] genetic variants as possible susceptibility factors for [E2]@DISEASE$[/E2] and fractures in humans.", "text_with_typed_entity_marker": "Our work supported [GENE]@GENE$[/GENE] genetic variants as possible susceptibility factors for [DISEASE]@DISEASE$[/DISEASE] and fractures in humans.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [82, 91], "entity_2_idx_in_text_with_entity_marker": [95, 104], "entity_2_idx_in_text_with_typed_entity_marker": [104, 113], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_132", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, @GENE$, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, [E2]@GENE$[/E2], ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, [GENE]@GENE$[/GENE], ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [628, 634], "entity_2_idx_in_text_with_entity_marker": [641, 647], "entity_2_idx_in_text_with_typed_entity_marker": [653, 659], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_133", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene @GENE$ ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene [E2]@GENE$[/E2] ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene [GENE]@GENE$[/GENE] ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [600, 606], "entity_2_idx_in_text_with_entity_marker": [613, 619], "entity_2_idx_in_text_with_typed_entity_marker": [625, 631], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_134", "text": "@DISEASE$ patients have impaired @GENE$ secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] patients have impaired [E2]@GENE$[/E2] secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] patients have impaired [GENE]@GENE$[/GENE] secretion via NOD2-dependent and -independent pathways and display an impaired NOD2-dependent down-regulation of TNF-alpha secretion.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [33, 39], "entity_2_idx_in_text_with_entity_marker": [46, 52], "entity_2_idx_in_text_with_typed_entity_marker": [58, 64], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_135", "text": "This study assessed associations between the @GENE$ gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 @DISEASE$ patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_entity_marker": "This study assessed associations between the [E1]@GENE$[/E1] gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 [E2]@DISEASE$[/E2] patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_typed_entity_marker": "This study assessed associations between the [GENE]@GENE$[/GENE] gene and myocardial infarction (MI), using a haplotype-based case-control study of 234 [DISEASE]@DISEASE$[/DISEASE] patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [139, 148], "entity_2_idx_in_text_with_entity_marker": [152, 161], "entity_2_idx_in_text_with_typed_entity_marker": [161, 170], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_136", "text": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in @DISEASE$ cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of @GENE$ signaling.", "text_with_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [E1]@DISEASE$[/E1] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of [E2]@GENE$[/E2] signaling.", "text_with_typed_entity_marker": "These results suggest that gsp mutations up-regulate GHRHR mRNA expression in [DISEASE]@DISEASE$[/DISEASE] cells, and that gsp mutations desensitize the adenoma cells to GHRH in terms of their GHRHR mRNA expression probably because of their saturation of [GENE]@GENE$[/GENE] signaling.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [78, 87], "entity_1_idx_in_text_with_entity_marker": [82, 91], "entity_1_idx_in_text_with_typed_entity_marker": [87, 96], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [236, 242], "entity_2_idx_in_text_with_entity_marker": [249, 255], "entity_2_idx_in_text_with_typed_entity_marker": [261, 267], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_137", "text": "Furthermore, we show that the HIV-DNA levels (reflecting the @DISEASE$ reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the @GENE$ gene).", "text_with_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [E1]@DISEASE$[/E1] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [E2]@GENE$[/E2] gene).", "text_with_typed_entity_marker": "Furthermore, we show that the HIV-DNA levels (reflecting the [DISEASE]@DISEASE$[/DISEASE] reservoir) are associated with the same four SNPs, but also with two additional SNPs on chromosome 17 (rs6503919; intergenic region flanked by the DDX40 and YPEL2 genes) and chromosome 8 (rs2575735; within the [GENE]@GENE$[/GENE] gene).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [61, 70], "entity_1_idx_in_text_with_entity_marker": [65, 74], "entity_1_idx_in_text_with_typed_entity_marker": [70, 79], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [281, 287], "entity_2_idx_in_text_with_entity_marker": [294, 300], "entity_2_idx_in_text_with_typed_entity_marker": [306, 312], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_138", "text": "Anti-@GENE$ antibody passage across the blood-brain barrier in the SAMP8 mouse model of @DISEASE$: an age-related selective uptake with reversal of learning impairment.", "text_with_entity_marker": "Anti-[E1]@GENE$[/E1] antibody passage across the blood-brain barrier in the SAMP8 mouse model of [E2]@DISEASE$[/E2]: an age-related selective uptake with reversal of learning impairment.", "text_with_typed_entity_marker": "Anti-[GENE]@GENE$[/GENE] antibody passage across the blood-brain barrier in the SAMP8 mouse model of [DISEASE]@DISEASE$[/DISEASE]: an age-related selective uptake with reversal of learning impairment.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [5, 11], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_idx_in_text_with_typed_entity_marker": [11, 17], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_139", "text": "Compound heterozygosity for the C677T and @GENE$ gene in a case of @DISEASE$ with recurrent deep thrombosis at young age.", "text_with_entity_marker": "Compound heterozygosity for the C677T and [E1]@GENE$[/E1] gene in a case of [E2]@DISEASE$[/E2] with recurrent deep thrombosis at young age.", "text_with_typed_entity_marker": "Compound heterozygosity for the C677T and [GENE]@GENE$[/GENE] gene in a case of [DISEASE]@DISEASE$[/DISEASE] with recurrent deep thrombosis at young age.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [42, 48], "entity_1_idx_in_text_with_entity_marker": [46, 52], "entity_1_idx_in_text_with_typed_entity_marker": [48, 54], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [67, 76], "entity_2_idx_in_text_with_entity_marker": [80, 89], "entity_2_idx_in_text_with_typed_entity_marker": [89, 98], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_140", "text": "Failure of medical and surgical therapy in @DISEASE$ is associated with significantly decreased expression of @GENE$.", "text_with_entity_marker": "Failure of medical and surgical therapy in [E1]@DISEASE$[/E1] is associated with significantly decreased expression of [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "Failure of medical and surgical therapy in [DISEASE]@DISEASE$[/DISEASE] is associated with significantly decreased expression of [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [43, 52], "entity_1_idx_in_text_with_entity_marker": [47, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 61], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [110, 116], "entity_2_idx_in_text_with_entity_marker": [123, 129], "entity_2_idx_in_text_with_typed_entity_marker": [135, 141], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_141", "text": "Recently an association was shown between the single nucleotide polymorphism (SNP), @GENE$, within the interleukin-23 receptor (IL23R) locus and Crohn's disease (@DISEASE$) as a consequence of a genome-wide association study of this disease in adults.", "text_with_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [E1]@GENE$[/E1], within the interleukin-23 receptor (IL23R) locus and Crohn's disease ([E2]@DISEASE$[/E2]) as a consequence of a genome-wide association study of this disease in adults.", "text_with_typed_entity_marker": "Recently an association was shown between the single nucleotide polymorphism (SNP), [GENE]@GENE$[/GENE], within the interleukin-23 receptor (IL23R) locus and Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]) as a consequence of a genome-wide association study of this disease in adults.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [84, 90], "entity_1_idx_in_text_with_entity_marker": [88, 94], "entity_1_idx_in_text_with_typed_entity_marker": [90, 96], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [162, 171], "entity_2_idx_in_text_with_entity_marker": [175, 184], "entity_2_idx_in_text_with_typed_entity_marker": [184, 193], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_142", "text": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a @GENE$-dependent disease risk factor.", "text_with_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [E1]@DISEASE$[/E1] and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a [E2]@GENE$[/E2]-dependent disease risk factor.", "text_with_typed_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE] and is consistent with the hypothesis that impaired GM-CSF secretion in part constitutes a [GENE]@GENE$[/GENE]-dependent disease risk factor.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [95, 104], "entity_1_idx_in_text_with_entity_marker": [99, 108], "entity_1_idx_in_text_with_typed_entity_marker": [104, 113], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [196, 202], "entity_2_idx_in_text_with_entity_marker": [209, 215], "entity_2_idx_in_text_with_typed_entity_marker": [221, 227], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_143", "text": "These results suggest that @GENE$ may be involved in genetic susceptibility to @DISEASE$.", "text_with_entity_marker": "These results suggest that [E1]@GENE$[/E1] may be involved in genetic susceptibility to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results suggest that [GENE]@GENE$[/GENE] may be involved in genetic susceptibility to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [27, 33], "entity_1_idx_in_text_with_entity_marker": [31, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 39], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [79, 88], "entity_2_idx_in_text_with_entity_marker": [92, 101], "entity_2_idx_in_text_with_typed_entity_marker": [101, 110], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_144", "text": "A haplotype of the @GENE$ gene associated with @DISEASE$ in Japanese men.", "text_with_entity_marker": "A haplotype of the [E1]@GENE$[/E1] gene associated with [E2]@DISEASE$[/E2] in Japanese men.", "text_with_typed_entity_marker": "A haplotype of the [GENE]@GENE$[/GENE] gene associated with [DISEASE]@DISEASE$[/DISEASE] in Japanese men.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [47, 56], "entity_2_idx_in_text_with_entity_marker": [60, 69], "entity_2_idx_in_text_with_typed_entity_marker": [69, 78], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_145", "text": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of @DISEASE$ and is consistent with the hypothesis that impaired @GENE$ secretion in part constitutes a NOD2-dependent disease risk factor.", "text_with_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [E1]@DISEASE$[/E1] and is consistent with the hypothesis that impaired [E2]@GENE$[/E2] secretion in part constitutes a NOD2-dependent disease risk factor.", "text_with_typed_entity_marker": "The defect in GM-CSF secretion suggests a hitherto unknown role of NOD2 in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE] and is consistent with the hypothesis that impaired [GENE]@GENE$[/GENE] secretion in part constitutes a NOD2-dependent disease risk factor.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [95, 104], "entity_1_idx_in_text_with_entity_marker": [99, 108], "entity_1_idx_in_text_with_typed_entity_marker": [104, 113], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [157, 163], "entity_2_idx_in_text_with_entity_marker": [170, 176], "entity_2_idx_in_text_with_typed_entity_marker": [182, 188], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_146", "text": "To assess clinical significance, 93 @DISEASE$ lesions were evaluated for expression of @GENE$ and VEGFR-1 by immunohistochemistry.", "text_with_entity_marker": "To assess clinical significance, 93 [E1]@DISEASE$[/E1] lesions were evaluated for expression of [E2]@GENE$[/E2] and VEGFR-1 by immunohistochemistry.", "text_with_typed_entity_marker": "To assess clinical significance, 93 [DISEASE]@DISEASE$[/DISEASE] lesions were evaluated for expression of [GENE]@GENE$[/GENE] and VEGFR-1 by immunohistochemistry.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [36, 45], "entity_1_idx_in_text_with_entity_marker": [40, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 54], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [87, 93], "entity_2_idx_in_text_with_entity_marker": [100, 106], "entity_2_idx_in_text_with_typed_entity_marker": [112, 118], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_147", "text": "No significant associations were observed for @DISEASE$ (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; @GENE$: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "text_with_entity_marker": "No significant associations were observed for [E1]@DISEASE$[/E1] (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; [E2]@GENE$[/E2]: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "text_with_typed_entity_marker": "No significant associations were observed for [DISEASE]@DISEASE$[/DISEASE] (rs3020781: pAF = 0.49, OR = 1.02 [0.96-1.10]; [GENE]@GENE$[/GENE]: pAF = 0.84, OR = 0.99 [0.93-1.06]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [46, 55], "entity_1_idx_in_text_with_entity_marker": [50, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 64], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [103, 109], "entity_2_idx_in_text_with_entity_marker": [116, 122], "entity_2_idx_in_text_with_typed_entity_marker": [128, 134], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_148", "text": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the @GENE$ in the susceptibility to acute-onset and other forms of @DISEASE$ in the Japanese population.", "text_with_entity_marker": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the [E1]@GENE$[/E1] in the susceptibility to acute-onset and other forms of [E2]@DISEASE$[/E2] in the Japanese population.", "text_with_typed_entity_marker": "The present data confirm the type 1 diabetes association with IL2RA and provide evidence that the different contributions of the [GENE]@GENE$[/GENE] in the susceptibility to acute-onset and other forms of [DISEASE]@DISEASE$[/DISEASE] in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [129, 135], "entity_1_idx_in_text_with_entity_marker": [133, 139], "entity_1_idx_in_text_with_typed_entity_marker": [135, 141], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [192, 201], "entity_2_idx_in_text_with_entity_marker": [205, 214], "entity_2_idx_in_text_with_typed_entity_marker": [214, 223], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_149", "text": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase (@GENE$) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.", "text_with_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase ([E1]@GENE$[/E1]) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [E2]@DISEASE$[/E2] and can serve as biomarkers for screening for this virulent disease.", "text_with_typed_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) matrix metalloproteinase ([GENE]@GENE$[/GENE]) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [DISEASE]@DISEASE$[/DISEASE] and can serve as biomarkers for screening for this virulent disease.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [180, 186], "entity_1_idx_in_text_with_entity_marker": [184, 190], "entity_1_idx_in_text_with_typed_entity_marker": [186, 192], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [676, 685], "entity_2_idx_in_text_with_entity_marker": [689, 698], "entity_2_idx_in_text_with_typed_entity_marker": [698, 707], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_150", "text": "Compound heterozygosity for the @GENE$ and A1298C mutations of the MTHFR gene in a case of @DISEASE$ with recurrent deep thrombosis at young age.", "text_with_entity_marker": "Compound heterozygosity for the [E1]@GENE$[/E1] and A1298C mutations of the MTHFR gene in a case of [E2]@DISEASE$[/E2] with recurrent deep thrombosis at young age.", "text_with_typed_entity_marker": "Compound heterozygosity for the [GENE]@GENE$[/GENE] and A1298C mutations of the MTHFR gene in a case of [DISEASE]@DISEASE$[/DISEASE] with recurrent deep thrombosis at young age.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [32, 38], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 44], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [91, 100], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_idx_in_text_with_typed_entity_marker": [113, 122], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_151", "text": "Overall and relapse-free survival in @DISEASE$ and hypopharyngeal squamous cell carcinoma are associated with genotypes of @GENE$ gene.", "text_with_entity_marker": "Overall and relapse-free survival in [E1]@DISEASE$[/E1] and hypopharyngeal squamous cell carcinoma are associated with genotypes of [E2]@GENE$[/E2] gene.", "text_with_typed_entity_marker": "Overall and relapse-free survival in [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal squamous cell carcinoma are associated with genotypes of [GENE]@GENE$[/GENE] gene.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [37, 46], "entity_1_idx_in_text_with_entity_marker": [41, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 55], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [123, 129], "entity_2_idx_in_text_with_entity_marker": [136, 142], "entity_2_idx_in_text_with_typed_entity_marker": [148, 154], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_152", "text": "Vascular endothelial growth factor (@GENE$) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "text_with_entity_marker": "Vascular endothelial growth factor ([E1]@GENE$[/E1]) promotes [E2]@DISEASE$[/E2] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "text_with_typed_entity_marker": "Vascular endothelial growth factor ([GENE]@GENE$[/GENE]) promotes [DISEASE]@DISEASE$[/DISEASE] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (Flt-1) expressed on tumour cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [36, 42], "entity_1_idx_in_text_with_entity_marker": [40, 46], "entity_1_idx_in_text_with_typed_entity_marker": [42, 48], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_153", "text": "@GENE$ protein is an extracellular matrix molecule initially cloned from human @DISEASE$ cells treated with TGF-beta.", "text_with_entity_marker": "[E1]@GENE$[/E1] protein is an extracellular matrix molecule initially cloned from human [E2]@DISEASE$[/E2] cells treated with TGF-beta.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] protein is an extracellular matrix molecule initially cloned from human [DISEASE]@DISEASE$[/DISEASE] cells treated with TGF-beta.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [79, 88], "entity_2_idx_in_text_with_entity_marker": [92, 101], "entity_2_idx_in_text_with_typed_entity_marker": [101, 110], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_154", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and manic disorders, including schizophrenia and @DISEASE$.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both psychotic and manic disorders, including schizophrenia and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both psychotic and manic disorders, including schizophrenia and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [160, 169], "entity_2_idx_in_text_with_entity_marker": [173, 182], "entity_2_idx_in_text_with_typed_entity_marker": [182, 191], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_155", "text": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) @GENE$ (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to @DISEASE$ and can serve as biomarkers for screening for this virulent disease.", "text_with_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [E1]@GENE$[/E1] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [E2]@DISEASE$[/E2] and can serve as biomarkers for screening for this virulent disease.", "text_with_typed_entity_marker": "Analysis yielded the following Yale-generated observations: (1) TAA is a genetic disease with a predominantly autosomal dominant mode of inheritance; (2) [GENE]@GENE$[/GENE] (MMP) enzymes are activated in the pathogenesis of TAA; (3) wall tension in TAA approaches the tensile limits of aortic tissue at a diameter of 6 cm; (4) by the time a TAA reaches a clinical diameter of 6 cm, 34 percent of affected patients have suffered dissection or rupture; (5) extreme physical exertion or severe emotion often precipitate acute dissection; and (6) single nucleotide polymorphisms (SNPs) and RNA expression profile changes are being identified that predispose a patient to [DISEASE]@DISEASE$[/DISEASE] and can serve as biomarkers for screening for this virulent disease.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [154, 160], "entity_1_idx_in_text_with_entity_marker": [158, 164], "entity_1_idx_in_text_with_typed_entity_marker": [160, 166], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [655, 664], "entity_2_idx_in_text_with_entity_marker": [668, 677], "entity_2_idx_in_text_with_typed_entity_marker": [677, 686], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_156", "text": "In the independent trio samples, rs1937970-A and @GENE$ consistently showed significant under-transmission to @DISEASE$ offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_entity_marker": "In the independent trio samples, rs1937970-A and [E1]@GENE$[/E1] consistently showed significant under-transmission to [E2]@DISEASE$[/E2] offspring (unadjusted p = .003 and p = .004, respectively).", "text_with_typed_entity_marker": "In the independent trio samples, rs1937970-A and [GENE]@GENE$[/GENE] consistently showed significant under-transmission to [DISEASE]@DISEASE$[/DISEASE] offspring (unadjusted p = .003 and p = .004, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [49, 55], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 61], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [110, 119], "entity_2_idx_in_text_with_entity_marker": [123, 132], "entity_2_idx_in_text_with_typed_entity_marker": [132, 141], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_157", "text": "In humans, loss-of-function of the cilia-centrosomal protein @GENE$ is associated with Joubert and @DISEASE$, whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [E1]@GENE$[/E1] is associated with Joubert and [E2]@DISEASE$[/E2], whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "text_with_typed_entity_marker": "In humans, loss-of-function of the cilia-centrosomal protein [GENE]@GENE$[/GENE] is associated with Joubert and [DISEASE]@DISEASE$[/DISEASE], whereas hypomorphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [99, 108], "entity_2_idx_in_text_with_entity_marker": [112, 121], "entity_2_idx_in_text_with_typed_entity_marker": [121, 130], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_158", "text": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the @GENE$ ligand, muramyl dipeptide, was impaired significantly in @DISEASE$ patients.", "text_with_entity_marker": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the [E1]@GENE$[/E1] ligand, muramyl dipeptide, was impaired significantly in [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Moreover, TNF-alpha production was induced by a TLR-2 ligand, but a down-regulatory function by the [GENE]@GENE$[/GENE] ligand, muramyl dipeptide, was impaired significantly in [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [100, 106], "entity_1_idx_in_text_with_entity_marker": [104, 110], "entity_1_idx_in_text_with_typed_entity_marker": [106, 112], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [164, 173], "entity_2_idx_in_text_with_entity_marker": [177, 186], "entity_2_idx_in_text_with_typed_entity_marker": [186, 195], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_159", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (@GENE$) to @DISEASE$ (CD) risk in general and of the IL23R R381Q variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene ([E1]@GENE$[/E1]) to [E2]@DISEASE$[/E2] (CD) risk in general and of the IL23R R381Q variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene ([GENE]@GENE$[/GENE]) to [DISEASE]@DISEASE$[/DISEASE] (CD) risk in general and of the IL23R R381Q variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [92, 98], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_idx_in_text_with_typed_entity_marker": [98, 104], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_160", "text": "Especially, the SNP @GENE$ and its strongly associated SNPs (e.g., rs1784235) could be important to human @DISEASE$ phenotypes.", "text_with_entity_marker": "Especially, the SNP [E1]@GENE$[/E1] and its strongly associated SNPs (e.g., rs1784235) could be important to human [E2]@DISEASE$[/E2] phenotypes.", "text_with_typed_entity_marker": "Especially, the SNP [GENE]@GENE$[/GENE] and its strongly associated SNPs (e.g., rs1784235) could be important to human [DISEASE]@DISEASE$[/DISEASE] phenotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [106, 115], "entity_2_idx_in_text_with_entity_marker": [119, 128], "entity_2_idx_in_text_with_typed_entity_marker": [128, 137], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_161", "text": "Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (@DISEASE$) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer ([E2]@DISEASE$[/E2]) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer ([DISEASE]@DISEASE$[/DISEASE]) or malignant melanoma (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_162", "text": "The TIMP-1 genotype TT in women and T in men at @GENE$ was found to increase @DISEASE$ susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_entity_marker": "The TIMP-1 genotype TT in women and T in men at [E1]@GENE$[/E1] was found to increase [E2]@DISEASE$[/E2] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "text_with_typed_entity_marker": "The TIMP-1 genotype TT in women and T in men at [GENE]@GENE$[/GENE] was found to increase [DISEASE]@DISEASE$[/DISEASE] susceptibility (39% vs 23.8%, P = 0.018 and 67.9% vs 51.6%, P = 0.055, respectively), while women with this genotype were less prone to development of fistulae during follow-up (41.4% vs 68.3%, P = 0.025).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_163", "text": "This first replication study confirms the association of genetic variation in the upstream region of @GENE$ with susceptibility to @DISEASE$.", "text_with_entity_marker": "This first replication study confirms the association of genetic variation in the upstream region of [E1]@GENE$[/E1] with susceptibility to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "This first replication study confirms the association of genetic variation in the upstream region of [GENE]@GENE$[/GENE] with susceptibility to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [101, 107], "entity_1_idx_in_text_with_entity_marker": [105, 111], "entity_1_idx_in_text_with_typed_entity_marker": [107, 113], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [131, 140], "entity_2_idx_in_text_with_entity_marker": [144, 153], "entity_2_idx_in_text_with_typed_entity_marker": [153, 162], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_164", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and @GENE$, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and [E2]@GENE$[/E2], conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and [GENE]@GENE$[/GENE], conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [479, 485], "entity_2_idx_in_text_with_entity_marker": [492, 498], "entity_2_idx_in_text_with_typed_entity_marker": [504, 510], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_165", "text": "The expression of GHRH receptor (GHRHR) is regulated by @GENE$, both of which are known to be expressed in human @DISEASE$ cells.", "text_with_entity_marker": "The expression of GHRH receptor (GHRHR) is regulated by [E1]@GENE$[/E1], both of which are known to be expressed in human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "The expression of GHRH receptor (GHRHR) is regulated by [GENE]@GENE$[/GENE], both of which are known to be expressed in human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [113, 122], "entity_2_idx_in_text_with_entity_marker": [126, 135], "entity_2_idx_in_text_with_typed_entity_marker": [135, 144], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_166", "text": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling @GENE$ level in carriers of @DISEASE$.", "text_with_entity_marker": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling [E1]@GENE$[/E1] level in carriers of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The HBS1L-MYB intergenic region on chromosome 6q23 is a quantitative trait locus controlling [GENE]@GENE$[/GENE] level in carriers of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [93, 99], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 105], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [121, 130], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_idx_in_text_with_typed_entity_marker": [143, 152], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_167", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and @DISEASE$ in GPx1 and @GENE$ double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [E1]@DISEASE$[/E1] in GPx1 and [E2]@GENE$[/E2] double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of colitis and [DISEASE]@DISEASE$[/DISEASE] in GPx1 and [GENE]@GENE$[/GENE] double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [106, 115], "entity_1_idx_in_text_with_entity_marker": [110, 119], "entity_1_idx_in_text_with_typed_entity_marker": [115, 124], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [128, 134], "entity_2_idx_in_text_with_entity_marker": [141, 147], "entity_2_idx_in_text_with_typed_entity_marker": [153, 159], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_168", "text": "In contrast, enhanced @GENE$ expression is consistently associated with @DISEASE$.", "text_with_entity_marker": "In contrast, enhanced [E1]@GENE$[/E1] expression is consistently associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In contrast, enhanced [GENE]@GENE$[/GENE] expression is consistently associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_169", "text": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as @GENE$ and TNF-alpha-G308A.", "text_with_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with [E1]@DISEASE$[/E1] to the same extent as [E2]@GENE$[/E2] and TNF-alpha-G308A.", "text_with_typed_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with [DISEASE]@DISEASE$[/DISEASE] to the same extent as [GENE]@GENE$[/GENE] and TNF-alpha-G308A.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [164, 173], "entity_1_idx_in_text_with_entity_marker": [168, 177], "entity_1_idx_in_text_with_typed_entity_marker": [173, 182], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [196, 202], "entity_2_idx_in_text_with_entity_marker": [209, 215], "entity_2_idx_in_text_with_typed_entity_marker": [221, 227], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_170", "text": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and @GENE$, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and [E1]@GENE$[/E1], are involved with [E2]@DISEASE$[/E2] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_typed_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and [GENE]@GENE$[/GENE], are involved with [DISEASE]@DISEASE$[/DISEASE] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [133, 139], "entity_1_idx_in_text_with_entity_marker": [137, 143], "entity_1_idx_in_text_with_typed_entity_marker": [139, 145], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [159, 168], "entity_2_idx_in_text_with_entity_marker": [172, 181], "entity_2_idx_in_text_with_typed_entity_marker": [181, 190], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_171", "text": "Interestingly, the diplotype @GENE$ also conferred an increased risk of @DISEASE$ (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "text_with_entity_marker": "Interestingly, the diplotype [E1]@GENE$[/E1] also conferred an increased risk of [E2]@DISEASE$[/E2] (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "text_with_typed_entity_marker": "Interestingly, the diplotype [GENE]@GENE$[/GENE] also conferred an increased risk of [DISEASE]@DISEASE$[/DISEASE] (OR 1.76, 95% CI 1.22-2.54, P=0.003).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [29, 35], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_idx_in_text_with_typed_entity_marker": [35, 41], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_172", "text": "On multivariate analysis the @GENE$ (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for @DISEASE$ (grade 3 or greater) throughout the period of chemotherapy.", "text_with_entity_marker": "On multivariate analysis the [E1]@GENE$[/E1] (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for [E2]@DISEASE$[/E2] (grade 3 or greater) throughout the period of chemotherapy.", "text_with_typed_entity_marker": "On multivariate analysis the [GENE]@GENE$[/GENE] (OR 8.205, 95% CI 1.616-41.667, p = 0.011) and smaller number of treatment cycles (OR 0.156, 95% CI 0.037-0.659, p = 0.011) were independent factors for [DISEASE]@DISEASE$[/DISEASE] (grade 3 or greater) throughout the period of chemotherapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [29, 35], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_idx_in_text_with_typed_entity_marker": [35, 41], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [189, 198], "entity_2_idx_in_text_with_entity_marker": [202, 211], "entity_2_idx_in_text_with_typed_entity_marker": [211, 220], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_173", "text": "@GENE$ provide a large population attributable risk for @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] provide a large population attributable risk for [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] provide a large population attributable risk for [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [56, 65], "entity_2_idx_in_text_with_entity_marker": [69, 78], "entity_2_idx_in_text_with_typed_entity_marker": [78, 87], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_174", "text": "The @GENE$ increased the chance of stenotic complications in @DISEASE$ during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_entity_marker": "The [E1]@GENE$[/E1] increased the chance of stenotic complications in [E2]@DISEASE$[/E2] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] increased the chance of stenotic complications in [DISEASE]@DISEASE$[/DISEASE] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [61, 70], "entity_2_idx_in_text_with_entity_marker": [74, 83], "entity_2_idx_in_text_with_typed_entity_marker": [83, 92], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_175", "text": "In case-control samples, two SNPs (rs1937970 and @GENE$) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs (rs1937970 and [E1]@GENE$[/E1]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs (rs1937970 and [GENE]@GENE$[/GENE]) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [49, 55], "entity_1_idx_in_text_with_entity_marker": [53, 59], "entity_1_idx_in_text_with_typed_entity_marker": [55, 61], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_176", "text": "Vitamin D receptor (@GENE$) genotypes may influence @DISEASE$ risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence [E2]@DISEASE$[/E2] risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence [DISEASE]@DISEASE$[/DISEASE] risk; however, no epidemiological studies in sporadic breast cancer (BC) or malignant melanoma (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [52, 61], "entity_2_idx_in_text_with_entity_marker": [65, 74], "entity_2_idx_in_text_with_typed_entity_marker": [74, 83], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_177", "text": "@GENE$ constructed by the two SNPs was also significantly associated with @DISEASE$ (permutation p value = .0047).", "text_with_entity_marker": "[E1]@GENE$[/E1] constructed by the two SNPs was also significantly associated with [E2]@DISEASE$[/E2] (permutation p value = .0047).", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] constructed by the two SNPs was also significantly associated with [DISEASE]@DISEASE$[/DISEASE] (permutation p value = .0047).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [74, 83], "entity_2_idx_in_text_with_entity_marker": [87, 96], "entity_2_idx_in_text_with_typed_entity_marker": [96, 105], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_178", "text": "In this study, the @GENE$ polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or @DISEASE$.", "text_with_entity_marker": "In this study, the [E1]@GENE$[/E1] polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In this study, the [GENE]@GENE$[/GENE] polymorphism observed in the MDR1 gene was not found to be a risk factor for Crohn's disease or [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [122, 131], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_idx_in_text_with_typed_entity_marker": [144, 153], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_179", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (@GENE$, nucleotide oligomerization domain 2) are associated with @DISEASE$ (CD).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([E1]@GENE$[/E1], nucleotide oligomerization domain 2) are associated with [E2]@DISEASE$[/E2] (CD).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([GENE]@GENE$[/GENE], nucleotide oligomerization domain 2) are associated with [DISEASE]@DISEASE$[/DISEASE] (CD).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [151, 157], "entity_1_idx_in_text_with_entity_marker": [155, 161], "entity_1_idx_in_text_with_typed_entity_marker": [157, 163], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [216, 225], "entity_2_idx_in_text_with_entity_marker": [229, 238], "entity_2_idx_in_text_with_typed_entity_marker": [238, 247], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_180", "text": "Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, [E2]@DISEASE$[/E2], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, [DISEASE]@DISEASE$[/DISEASE], obesity and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_181", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, @GENE$, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, [E1]@GENE$[/E1], rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (rs2395029, [GENE]@GENE$[/GENE], rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [91, 97], "entity_1_idx_in_text_with_entity_marker": [95, 101], "entity_1_idx_in_text_with_typed_entity_marker": [97, 103], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_182", "text": "The haplotypes constructed from the three SNPs (rs3840846, @GENE$ and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, [E1]@GENE$[/E1] and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs (rs3840846, [GENE]@GENE$[/GENE] and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [59, 65], "entity_1_idx_in_text_with_entity_marker": [63, 69], "entity_1_idx_in_text_with_typed_entity_marker": [65, 71], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_183", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (@DISEASE$) or bloody diarrhea than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([E2]@DISEASE$[/E2]) or bloody diarrhea than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome ([DISEASE]@DISEASE$[/DISEASE]) or bloody diarrhea than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_184", "text": "Compared with the epsilon3 homozygotes, neither the @GENE$ nor the epsilon4 carrier status was associated with @DISEASE$ (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_entity_marker": "Compared with the epsilon3 homozygotes, neither the [E1]@GENE$[/E1] nor the epsilon4 carrier status was associated with [E2]@DISEASE$[/E2] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "text_with_typed_entity_marker": "Compared with the epsilon3 homozygotes, neither the [GENE]@GENE$[/GENE] nor the epsilon4 carrier status was associated with [DISEASE]@DISEASE$[/DISEASE] (adjusted prevalence ratios = 0.94, 95%CI = 0.83-1.07 and 0.98, 0.89-1.07, respectively).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [52, 58], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_idx_in_text_with_typed_entity_marker": [58, 64], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [111, 120], "entity_2_idx_in_text_with_entity_marker": [124, 133], "entity_2_idx_in_text_with_typed_entity_marker": [133, 142], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_185", "text": "Therefore, the mutations of the @GENE$ gene are thought to be related with the pathogenesis of @DISEASE$.", "text_with_entity_marker": "Therefore, the mutations of the [E1]@GENE$[/E1] gene are thought to be related with the pathogenesis of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Therefore, the mutations of the [GENE]@GENE$[/GENE] gene are thought to be related with the pathogenesis of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [32, 38], "entity_1_idx_in_text_with_entity_marker": [36, 42], "entity_1_idx_in_text_with_typed_entity_marker": [38, 44], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [95, 104], "entity_2_idx_in_text_with_entity_marker": [108, 117], "entity_2_idx_in_text_with_typed_entity_marker": [117, 126], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_186", "text": "The synonymous variant @GENE$ (TaqI) appeared to be associated with protection from @DISEASE$ (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).", "text_with_entity_marker": "The synonymous variant [E1]@GENE$[/E1] (TaqI) appeared to be associated with protection from [E2]@DISEASE$[/E2] (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).", "text_with_typed_entity_marker": "The synonymous variant [GENE]@GENE$[/GENE] (TaqI) appeared to be associated with protection from [DISEASE]@DISEASE$[/DISEASE] (OR = 0.80, 95%CI = 0.64-0.99; p = 0.047).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [84, 93], "entity_2_idx_in_text_with_entity_marker": [97, 106], "entity_2_idx_in_text_with_typed_entity_marker": [106, 115], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_187", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease (@DISEASE$) risk in general and of the @GENE$ variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease ([E1]@DISEASE$[/E1]) risk in general and of the [E2]@GENE$[/E2] variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]) risk in general and of the [GENE]@GENE$[/GENE] variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [119, 128], "entity_1_idx_in_text_with_entity_marker": [123, 132], "entity_1_idx_in_text_with_typed_entity_marker": [128, 137], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [157, 163], "entity_2_idx_in_text_with_entity_marker": [170, 176], "entity_2_idx_in_text_with_typed_entity_marker": [182, 188], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_188", "text": "A recent study showed that LPA-mediated proliferation of @DISEASE$ cells requires activation of @GENE$.", "text_with_entity_marker": "A recent study showed that LPA-mediated proliferation of [E1]@DISEASE$[/E1] cells requires activation of [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "A recent study showed that LPA-mediated proliferation of [DISEASE]@DISEASE$[/DISEASE] cells requires activation of [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [57, 66], "entity_1_idx_in_text_with_entity_marker": [61, 70], "entity_1_idx_in_text_with_typed_entity_marker": [66, 75], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [96, 102], "entity_2_idx_in_text_with_entity_marker": [109, 115], "entity_2_idx_in_text_with_typed_entity_marker": [121, 127], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_189", "text": "Based on @GENE$ analyses, 41 @DISEASE$ patients and 12 healthy controls were studied.", "text_with_entity_marker": "Based on [E1]@GENE$[/E1] analyses, 41 [E2]@DISEASE$[/E2] patients and 12 healthy controls were studied.", "text_with_typed_entity_marker": "Based on [GENE]@GENE$[/GENE] analyses, 41 [DISEASE]@DISEASE$[/DISEASE] patients and 12 healthy controls were studied.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [9, 15], "entity_1_idx_in_text_with_entity_marker": [13, 19], "entity_1_idx_in_text_with_typed_entity_marker": [15, 21], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [29, 38], "entity_2_idx_in_text_with_entity_marker": [42, 51], "entity_2_idx_in_text_with_typed_entity_marker": [51, 60], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_190", "text": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and @GENE$) that are associated with @DISEASE$.", "text_with_entity_marker": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and [E1]@GENE$[/E1]) that are associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "We used a candidate gene approach to identify a set of SNPs, located in a predicted regulatory region on chromosome 1q44 downstream of NLRP3 (previously known as CIAS1 and [GENE]@GENE$[/GENE]) that are associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [172, 178], "entity_1_idx_in_text_with_entity_marker": [176, 182], "entity_1_idx_in_text_with_typed_entity_marker": [178, 184], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [205, 214], "entity_2_idx_in_text_with_entity_marker": [218, 227], "entity_2_idx_in_text_with_typed_entity_marker": [227, 236], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_191", "text": "Common variants in the @GENE$ region contribute to @DISEASE$ susceptibility.", "text_with_entity_marker": "Common variants in the [E1]@GENE$[/E1] region contribute to [E2]@DISEASE$[/E2] susceptibility.", "text_with_typed_entity_marker": "Common variants in the [GENE]@GENE$[/GENE] region contribute to [DISEASE]@DISEASE$[/DISEASE] susceptibility.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_192", "text": "Much of this data has been correlative, until recently with the development of @GENE$ deficient mice which accumulate high levels of mtDNA mutations and show a @DISEASE$ phenotype, that a more causative role has been proposed.", "text_with_entity_marker": "Much of this data has been correlative, until recently with the development of [E1]@GENE$[/E1] deficient mice which accumulate high levels of mtDNA mutations and show a [E2]@DISEASE$[/E2] phenotype, that a more causative role has been proposed.", "text_with_typed_entity_marker": "Much of this data has been correlative, until recently with the development of [GENE]@GENE$[/GENE] deficient mice which accumulate high levels of mtDNA mutations and show a [DISEASE]@DISEASE$[/DISEASE] phenotype, that a more causative role has been proposed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [79, 85], "entity_1_idx_in_text_with_entity_marker": [83, 89], "entity_1_idx_in_text_with_typed_entity_marker": [85, 91], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [160, 169], "entity_2_idx_in_text_with_entity_marker": [173, 182], "entity_2_idx_in_text_with_typed_entity_marker": [182, 191], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_193", "text": "We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and @DISEASE$, overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE], overweight, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [75, 81], "entity_1_idx_in_text_with_entity_marker": [79, 85], "entity_1_idx_in_text_with_typed_entity_marker": [81, 87], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_194", "text": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in @GENE$ and the occurrence of sporadic @DISEASE$ in Chinese patients.", "text_with_entity_marker": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in [E1]@GENE$[/E1] and the occurrence of sporadic [E2]@DISEASE$[/E2] in Chinese patients.", "text_with_typed_entity_marker": "In the present study, the authors investigated the correlation between the presence of the rs42524 polymorphism in [GENE]@GENE$[/GENE] and the occurrence of sporadic [DISEASE]@DISEASE$[/DISEASE] in Chinese patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [115, 121], "entity_1_idx_in_text_with_entity_marker": [119, 125], "entity_1_idx_in_text_with_typed_entity_marker": [121, 127], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [153, 162], "entity_2_idx_in_text_with_entity_marker": [166, 175], "entity_2_idx_in_text_with_typed_entity_marker": [175, 184], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_195", "text": "A recent study demonstrated the association of @GENE$ located in the upstream region with risk for or protection from systemic lupus erythematosus (@DISEASE$).", "text_with_entity_marker": "A recent study demonstrated the association of [E1]@GENE$[/E1] located in the upstream region with risk for or protection from systemic lupus erythematosus ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "A recent study demonstrated the association of [GENE]@GENE$[/GENE] located in the upstream region with risk for or protection from systemic lupus erythematosus ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [148, 157], "entity_2_idx_in_text_with_entity_marker": [161, 170], "entity_2_idx_in_text_with_typed_entity_marker": [170, 179], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_196", "text": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and @DISEASE$, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "text_with_entity_marker": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and [E1]@DISEASE$[/E1], relatively little research has compared the effects of various [E2]@GENE$[/E2] inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "text_with_typed_entity_marker": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including oral leukoplakia and [DISEASE]@DISEASE$[/DISEASE], relatively little research has compared the effects of various [GENE]@GENE$[/GENE] inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [126, 135], "entity_1_idx_in_text_with_entity_marker": [130, 139], "entity_1_idx_in_text_with_typed_entity_marker": [135, 144], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [200, 206], "entity_2_idx_in_text_with_entity_marker": [213, 219], "entity_2_idx_in_text_with_typed_entity_marker": [225, 231], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_197", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor (@GENE$ in the etiopathogenesis of inflammatory bowel diseases (@DISEASE$), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([E1]@GENE$[/E1] in the etiopathogenesis of inflammatory bowel diseases ([E2]@DISEASE$[/E2]), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, tissue inhibitors of metalloproteinases (TIMP)-1, -2 and tumor necrosis factor ([GENE]@GENE$[/GENE] in the etiopathogenesis of inflammatory bowel diseases ([DISEASE]@DISEASE$[/DISEASE]), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [223, 229], "entity_1_idx_in_text_with_entity_marker": [227, 233], "entity_1_idx_in_text_with_typed_entity_marker": [229, 235], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [286, 295], "entity_2_idx_in_text_with_entity_marker": [299, 308], "entity_2_idx_in_text_with_typed_entity_marker": [308, 317], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_198", "text": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (@GENE$ gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with @DISEASE$ and obesity.", "text_with_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([E1]@GENE$[/E1] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with [E2]@DISEASE$[/E2] and obesity.", "text_with_typed_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([GENE]@GENE$[/GENE] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with [DISEASE]@DISEASE$[/DISEASE] and obesity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [80, 86], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_idx_in_text_with_typed_entity_marker": [86, 92], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [193, 202], "entity_2_idx_in_text_with_entity_marker": [206, 215], "entity_2_idx_in_text_with_typed_entity_marker": [215, 224], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_199", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the @GENE$ polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the [E1]@GENE$[/E1] polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the [GENE]@GENE$[/GENE] polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [125, 131], "entity_1_idx_in_text_with_entity_marker": [129, 135], "entity_1_idx_in_text_with_typed_entity_marker": [131, 137], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [229, 238], "entity_2_idx_in_text_with_entity_marker": [242, 251], "entity_2_idx_in_text_with_typed_entity_marker": [251, 260], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_200", "text": "Further research is needed to determine the potential of @GENE$ as a therapeutic target in @DISEASE$.", "text_with_entity_marker": "Further research is needed to determine the potential of [E1]@GENE$[/E1] as a therapeutic target in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Further research is needed to determine the potential of [GENE]@GENE$[/GENE] as a therapeutic target in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [57, 63], "entity_1_idx_in_text_with_entity_marker": [61, 67], "entity_1_idx_in_text_with_typed_entity_marker": [63, 69], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [91, 100], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_idx_in_text_with_typed_entity_marker": [113, 122], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_201", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and @GENE$ ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and [E2]@GENE$[/E2] ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and [GENE]@GENE$[/GENE] ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [341, 347], "entity_2_idx_in_text_with_entity_marker": [354, 360], "entity_2_idx_in_text_with_typed_entity_marker": [366, 372], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_202", "text": "However, the contribution of common genetic variants in @GENE$ to the @DISEASE$ risk in Chinese populations has not been thoroughly investigated.", "text_with_entity_marker": "However, the contribution of common genetic variants in [E1]@GENE$[/E1] to the [E2]@DISEASE$[/E2] risk in Chinese populations has not been thoroughly investigated.", "text_with_typed_entity_marker": "However, the contribution of common genetic variants in [GENE]@GENE$[/GENE] to the [DISEASE]@DISEASE$[/DISEASE] risk in Chinese populations has not been thoroughly investigated.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_203", "text": "The result supports that the @GENE$ gene is a susceptibility gene for @DISEASE$.", "text_with_entity_marker": "The result supports that the [E1]@GENE$[/E1] gene is a susceptibility gene for [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The result supports that the [GENE]@GENE$[/GENE] gene is a susceptibility gene for [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [29, 35], "entity_1_idx_in_text_with_entity_marker": [33, 39], "entity_1_idx_in_text_with_typed_entity_marker": [35, 41], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_204", "text": "Our data provide evidence that the @GENE$ controls both HIV replication and @DISEASE$ reservoir.", "text_with_entity_marker": "Our data provide evidence that the [E1]@GENE$[/E1] controls both HIV replication and [E2]@DISEASE$[/E2] reservoir.", "text_with_typed_entity_marker": "Our data provide evidence that the [GENE]@GENE$[/GENE] controls both HIV replication and [DISEASE]@DISEASE$[/DISEASE] reservoir.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [76, 85], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_idx_in_text_with_typed_entity_marker": [98, 107], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_205", "text": "@GENE$ (HbF) level modifies the clinical severity of @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] (HbF) level modifies the clinical severity of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] (HbF) level modifies the clinical severity of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_206", "text": "In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with @GENE$ being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with [E1]@GENE$[/E1] being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs (rs1937970 and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with [GENE]@GENE$[/GENE] being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [150, 156], "entity_1_idx_in_text_with_entity_marker": [154, 160], "entity_1_idx_in_text_with_typed_entity_marker": [156, 162], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [183, 192], "entity_2_idx_in_text_with_entity_marker": [196, 205], "entity_2_idx_in_text_with_typed_entity_marker": [205, 214], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_207", "text": "In @DISEASE$ patients, TLR-induced @GENE$ secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, TLR-induced [E2]@GENE$[/E2] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, TLR-induced [GENE]@GENE$[/GENE] secretion was impaired by both NOD2-dependent and -independent mechanisms.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [35, 41], "entity_2_idx_in_text_with_entity_marker": [48, 54], "entity_2_idx_in_text_with_typed_entity_marker": [60, 66], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_208", "text": "These results suggest that the @GENE$ region is also implicated in the susceptibility of more common inflammatory diseases such as @DISEASE$.", "text_with_entity_marker": "These results suggest that the [E1]@GENE$[/E1] region is also implicated in the susceptibility of more common inflammatory diseases such as [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results suggest that the [GENE]@GENE$[/GENE] region is also implicated in the susceptibility of more common inflammatory diseases such as [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [131, 140], "entity_2_idx_in_text_with_entity_marker": [144, 153], "entity_2_idx_in_text_with_typed_entity_marker": [153, 162], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_209", "text": "Lack of association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_entity_marker": "Lack of association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, overweight, [E2]@DISEASE$[/E2] and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "text_with_typed_entity_marker": "Lack of association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, overweight, [DISEASE]@DISEASE$[/DISEASE] and related metabolic phenotypes in a Danish large-scale study: case-control studies and analyses of quantitative traits.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_210", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of @DISEASE$ (HUS) or bloody diarrhea than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of [E2]@DISEASE$[/E2] (HUS) or bloody diarrhea than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of [DISEASE]@DISEASE$[/DISEASE] (HUS) or bloody diarrhea than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [93, 102], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_idx_in_text_with_typed_entity_marker": [115, 124], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_211", "text": "Women carrying homozygous @GENE$ genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to His1104Asp or His1104His genotypes.", "text_with_entity_marker": "Women carrying homozygous [E1]@GENE$[/E1] genotypes had a significantly decreased risk of cervical or [E2]@DISEASE$[/E2] compared to His1104Asp or His1104His genotypes.", "text_with_typed_entity_marker": "Women carrying homozygous [GENE]@GENE$[/GENE] genotypes had a significantly decreased risk of cervical or [DISEASE]@DISEASE$[/DISEASE] compared to His1104Asp or His1104His genotypes.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [26, 32], "entity_1_idx_in_text_with_entity_marker": [30, 36], "entity_1_idx_in_text_with_typed_entity_marker": [32, 38], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [93, 102], "entity_2_idx_in_text_with_entity_marker": [106, 115], "entity_2_idx_in_text_with_typed_entity_marker": [115, 124], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_212", "text": "Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or @DISEASE$ (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or [E2]@DISEASE$[/E2] (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence cancer risk; however, no epidemiological studies in sporadic breast cancer (BC) or [DISEASE]@DISEASE$[/DISEASE] (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_213", "text": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and @GENE$.", "text_with_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with [E1]@DISEASE$[/E1] to the same extent as FcGIIIA G559T and [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on CARD15 gene, in particular G908R and L1007fsinsC, are involved with [DISEASE]@DISEASE$[/DISEASE] to the same extent as FcGIIIA G559T and [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [164, 173], "entity_1_idx_in_text_with_entity_marker": [168, 177], "entity_1_idx_in_text_with_typed_entity_marker": [173, 182], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [214, 220], "entity_2_idx_in_text_with_entity_marker": [227, 233], "entity_2_idx_in_text_with_typed_entity_marker": [239, 245], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_214", "text": "In all, 763 @DISEASE$ subjects and 254 controls were genotyped for single nucleotide polymorphisms in the @GENE$ gene using Illumina and ABI methods.", "text_with_entity_marker": "In all, 763 [E1]@DISEASE$[/E1] subjects and 254 controls were genotyped for single nucleotide polymorphisms in the [E2]@GENE$[/E2] gene using Illumina and ABI methods.", "text_with_typed_entity_marker": "In all, 763 [DISEASE]@DISEASE$[/DISEASE] subjects and 254 controls were genotyped for single nucleotide polymorphisms in the [GENE]@GENE$[/GENE] gene using Illumina and ABI methods.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [12, 21], "entity_1_idx_in_text_with_entity_marker": [16, 25], "entity_1_idx_in_text_with_typed_entity_marker": [21, 30], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [106, 112], "entity_2_idx_in_text_with_entity_marker": [119, 125], "entity_2_idx_in_text_with_typed_entity_marker": [131, 137], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_215", "text": "On the other hand, AA genome and A allele polymorphism in the @GENE$ gene nucleotide pair G-A 61 is a significant risk factor for @DISEASE$.", "text_with_entity_marker": "On the other hand, AA genome and A allele polymorphism in the [E1]@GENE$[/E1] gene nucleotide pair G-A 61 is a significant risk factor for [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "On the other hand, AA genome and A allele polymorphism in the [GENE]@GENE$[/GENE] gene nucleotide pair G-A 61 is a significant risk factor for [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [62, 68], "entity_1_idx_in_text_with_entity_marker": [66, 72], "entity_1_idx_in_text_with_typed_entity_marker": [68, 74], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [130, 139], "entity_2_idx_in_text_with_entity_marker": [143, 152], "entity_2_idx_in_text_with_typed_entity_marker": [152, 161], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_216", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and @DISEASE$, including schizophrenia and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both psychotic and [E2]@DISEASE$[/E2], including schizophrenia and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both psychotic and [DISEASE]@DISEASE$[/DISEASE], including schizophrenia and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [115, 124], "entity_2_idx_in_text_with_entity_marker": [128, 137], "entity_2_idx_in_text_with_typed_entity_marker": [137, 146], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_217", "text": "We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, @DISEASE$, obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, [E2]@DISEASE$[/E2], obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, [DISEASE]@DISEASE$[/DISEASE], obesity or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [75, 81], "entity_1_idx_in_text_with_entity_marker": [79, 85], "entity_1_idx_in_text_with_typed_entity_marker": [81, 87], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_218", "text": "Additionally, levels of @GENE$ were significantly lower in @DISEASE$ compared to controls and CRSsNP.", "text_with_entity_marker": "Additionally, levels of [E1]@GENE$[/E1] were significantly lower in [E2]@DISEASE$[/E2] compared to controls and CRSsNP.", "text_with_typed_entity_marker": "Additionally, levels of [GENE]@GENE$[/GENE] were significantly lower in [DISEASE]@DISEASE$[/DISEASE] compared to controls and CRSsNP.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [24, 30], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_idx_in_text_with_typed_entity_marker": [30, 36], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [59, 68], "entity_2_idx_in_text_with_entity_marker": [72, 81], "entity_2_idx_in_text_with_typed_entity_marker": [81, 90], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_219", "text": "The @GENE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from oropharyngeal and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [131, 140], "entity_2_idx_in_text_with_entity_marker": [144, 153], "entity_2_idx_in_text_with_typed_entity_marker": [153, 162], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_220", "text": "The @GENE$ SNP could be considered as a genetic marker to predict the clinical course of patients suffering from @DISEASE$ and hypopharyngeal cancer.", "text_with_entity_marker": "The [E1]@GENE$[/E1] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from [E2]@DISEASE$[/E2] and hypopharyngeal cancer.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] SNP could be considered as a genetic marker to predict the clinical course of patients suffering from [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal cancer.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [113, 122], "entity_2_idx_in_text_with_entity_marker": [126, 135], "entity_2_idx_in_text_with_typed_entity_marker": [135, 144], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_221", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in GPx1 and @GENE$ double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [E1]@DISEASE$[/E1] and intestinal cancer in GPx1 and [E2]@GENE$[/E2] double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [DISEASE]@DISEASE$[/DISEASE] and intestinal cancer in GPx1 and [GENE]@GENE$[/GENE] double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [94, 103], "entity_1_idx_in_text_with_entity_marker": [98, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 112], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [138, 144], "entity_2_idx_in_text_with_entity_marker": [151, 157], "entity_2_idx_in_text_with_typed_entity_marker": [163, 169], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_222", "text": "Additionally, the @GENE$ and the NOS1AP genotypes were demonstrated not to have a major influence on @DISEASE$.", "text_with_entity_marker": "Additionally, the [E1]@GENE$[/E1] and the NOS1AP genotypes were demonstrated not to have a major influence on [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, the [GENE]@GENE$[/GENE] and the NOS1AP genotypes were demonstrated not to have a major influence on [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_223", "text": "The commonly deleted region of the @DISEASE$ extends between the genes @GENE$ (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "text_with_entity_marker": "The commonly deleted region of the [E1]@DISEASE$[/E1] extends between the genes [E2]@GENE$[/E2] (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "text_with_typed_entity_marker": "The commonly deleted region of the [DISEASE]@DISEASE$[/DISEASE] extends between the genes [GENE]@GENE$[/GENE] (proximal boundary) and GLRA1 (distal boundary) and measures 2.9 Mb.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [35, 44], "entity_1_idx_in_text_with_entity_marker": [39, 48], "entity_1_idx_in_text_with_typed_entity_marker": [44, 53], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [71, 77], "entity_2_idx_in_text_with_entity_marker": [84, 90], "entity_2_idx_in_text_with_typed_entity_marker": [96, 102], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_224", "text": "Ala394Thr polymorphism in the clock gene @GENE$: a circadian modifier for the risk of @DISEASE$.", "text_with_entity_marker": "Ala394Thr polymorphism in the clock gene [E1]@GENE$[/E1]: a circadian modifier for the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Ala394Thr polymorphism in the clock gene [GENE]@GENE$[/GENE]: a circadian modifier for the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [41, 47], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 53], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_225", "text": "No association of XRCC3 Thr241Met or @GENE$ and @DISEASE$ was found.", "text_with_entity_marker": "No association of XRCC3 Thr241Met or [E1]@GENE$[/E1] and [E2]@DISEASE$[/E2] was found.", "text_with_typed_entity_marker": "No association of XRCC3 Thr241Met or [GENE]@GENE$[/GENE] and [DISEASE]@DISEASE$[/DISEASE] was found.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [37, 43], "entity_1_idx_in_text_with_entity_marker": [41, 47], "entity_1_idx_in_text_with_typed_entity_marker": [43, 49], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_226", "text": "Association of a genetic polymorphism in @GENE$ with @DISEASE$ and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "text_with_entity_marker": "Association of a genetic polymorphism in [E1]@GENE$[/E1] with [E2]@DISEASE$[/E2] and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "text_with_typed_entity_marker": "Association of a genetic polymorphism in [GENE]@GENE$[/GENE] with [DISEASE]@DISEASE$[/DISEASE] and hepatitis C virus core antigen levels in subjects in a hyperendemic area of Japan.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [41, 47], "entity_1_idx_in_text_with_entity_marker": [45, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 53], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [53, 62], "entity_2_idx_in_text_with_entity_marker": [66, 75], "entity_2_idx_in_text_with_typed_entity_marker": [75, 84], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_227", "text": "The prognostic value of the @GENE$ SNP was evaluated in an unselected series of patients treated with curative intent for @DISEASE$ and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "text_with_entity_marker": "The prognostic value of the [E1]@GENE$[/E1] SNP was evaluated in an unselected series of patients treated with curative intent for [E2]@DISEASE$[/E2] and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "text_with_typed_entity_marker": "The prognostic value of the [GENE]@GENE$[/GENE] SNP was evaluated in an unselected series of patients treated with curative intent for [DISEASE]@DISEASE$[/DISEASE] and hypopharyngeal squamous cell carcinomas, including all tumor stages with different therapeutic regimens.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [122, 131], "entity_2_idx_in_text_with_entity_marker": [135, 144], "entity_2_idx_in_text_with_typed_entity_marker": [144, 153], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_228", "text": "Moreover, protective alleles for four disease-associated SNPs in the @GENE$ locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the [E1]@GENE$[/E1] locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the [GENE]@GENE$[/GENE] locus (rs2395029, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [69, 75], "entity_1_idx_in_text_with_entity_marker": [73, 79], "entity_1_idx_in_text_with_typed_entity_marker": [75, 81], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [192, 201], "entity_2_idx_in_text_with_entity_marker": [205, 214], "entity_2_idx_in_text_with_typed_entity_marker": [214, 223], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_229", "text": "Variations in the @GENE$ gene impact on survival of patients with advanced @DISEASE$.", "text_with_entity_marker": "Variations in the [E1]@GENE$[/E1] gene impact on survival of patients with advanced [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Variations in the [GENE]@GENE$[/GENE] gene impact on survival of patients with advanced [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [75, 84], "entity_2_idx_in_text_with_entity_marker": [88, 97], "entity_2_idx_in_text_with_typed_entity_marker": [97, 106], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_230", "text": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A (@GENE$) and susceptibility to both HIV-1 @DISEASE$ and disease progression.", "text_with_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A ([E1]@GENE$[/E1]) and susceptibility to both HIV-1 [E2]@DISEASE$[/E2] and disease progression.", "text_with_typed_entity_marker": "Previous studies have demonstrated an association between polymorphisms in the regulatory regions of Cyclophilin A ([GENE]@GENE$[/GENE]) and susceptibility to both HIV-1 [DISEASE]@DISEASE$[/DISEASE] and disease progression.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [116, 122], "entity_1_idx_in_text_with_entity_marker": [120, 126], "entity_1_idx_in_text_with_typed_entity_marker": [122, 128], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [157, 166], "entity_2_idx_in_text_with_entity_marker": [170, 179], "entity_2_idx_in_text_with_typed_entity_marker": [179, 188], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_231", "text": "@GENE$ play crucial roles in DNA replication and @DISEASE$.", "text_with_entity_marker": "[E1]@GENE$[/E1] play crucial roles in DNA replication and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] play crucial roles in DNA replication and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [49, 58], "entity_2_idx_in_text_with_entity_marker": [62, 71], "entity_2_idx_in_text_with_typed_entity_marker": [71, 80], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_232", "text": "Of the 21 loci screened, RAD52 2259 and @GENE$ may be of importance to disease process and may be associated with @DISEASE$ risk in Saudi Arabian population.", "text_with_entity_marker": "Of the 21 loci screened, RAD52 2259 and [E1]@GENE$[/E1] may be of importance to disease process and may be associated with [E2]@DISEASE$[/E2] risk in Saudi Arabian population.", "text_with_typed_entity_marker": "Of the 21 loci screened, RAD52 2259 and [GENE]@GENE$[/GENE] may be of importance to disease process and may be associated with [DISEASE]@DISEASE$[/DISEASE] risk in Saudi Arabian population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [40, 46], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 52], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [114, 123], "entity_2_idx_in_text_with_entity_marker": [127, 136], "entity_2_idx_in_text_with_typed_entity_marker": [136, 145], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_233", "text": "In case-control samples, two SNPs (@GENE$ and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for @DISEASE$ (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_entity_marker": "In case-control samples, two SNPs ([E1]@GENE$[/E1] and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [E2]@DISEASE$[/E2] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "text_with_typed_entity_marker": "In case-control samples, two SNPs ([GENE]@GENE$[/GENE] and rs677221) showed significant genotypic and allelic association with schizophrenia (all p < .05) with rs677221-C being the risk allele for [DISEASE]@DISEASE$[/DISEASE] (uncorrected p = .001, odds ratio = 1.439, 95% confidence interval = 1.115-1.858).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [184, 193], "entity_2_idx_in_text_with_entity_marker": [197, 206], "entity_2_idx_in_text_with_typed_entity_marker": [206, 215], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_234", "text": "The @GENE$ and the T-allele of NOS1AP rs7538490 are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The [E1]@GENE$[/E1] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] and the T-allele of NOS1AP rs7538490 are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [88, 97], "entity_2_idx_in_text_with_entity_marker": [101, 110], "entity_2_idx_in_text_with_typed_entity_marker": [110, 119], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_235", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to @DISEASE$ (CD) risk in general and of the @GENE$ variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [E1]@DISEASE$[/E1] (CD) risk in general and of the [E2]@GENE$[/E2] variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (IL23R) to [DISEASE]@DISEASE$[/DISEASE] (CD) risk in general and of the [GENE]@GENE$[/GENE] variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [102, 111], "entity_1_idx_in_text_with_entity_marker": [106, 115], "entity_1_idx_in_text_with_typed_entity_marker": [111, 120], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [144, 150], "entity_2_idx_in_text_with_entity_marker": [157, 163], "entity_2_idx_in_text_with_typed_entity_marker": [169, 175], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_236", "text": "The present study suggests that genetic variation in or near the @GENE$ gene is associated with both psychotic and manic disorders, including @DISEASE$ and bipolar disorder.", "text_with_entity_marker": "The present study suggests that genetic variation in or near the [E1]@GENE$[/E1] gene is associated with both psychotic and manic disorders, including [E2]@DISEASE$[/E2] and bipolar disorder.", "text_with_typed_entity_marker": "The present study suggests that genetic variation in or near the [GENE]@GENE$[/GENE] gene is associated with both psychotic and manic disorders, including [DISEASE]@DISEASE$[/DISEASE] and bipolar disorder.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [65, 71], "entity_1_idx_in_text_with_entity_marker": [69, 75], "entity_1_idx_in_text_with_typed_entity_marker": [71, 77], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [142, 151], "entity_2_idx_in_text_with_entity_marker": [155, 164], "entity_2_idx_in_text_with_typed_entity_marker": [164, 173], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_237", "text": "Vitamin D receptor (@GENE$) genotypes may influence cancer risk; however, no epidemiological studies in @DISEASE$ (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_entity_marker": "Vitamin D receptor ([E1]@GENE$[/E1]) genotypes may influence cancer risk; however, no epidemiological studies in [E2]@DISEASE$[/E2] (BC) or malignant melanoma (MM) have been performed in a southern European population.", "text_with_typed_entity_marker": "Vitamin D receptor ([GENE]@GENE$[/GENE]) genotypes may influence cancer risk; however, no epidemiological studies in [DISEASE]@DISEASE$[/DISEASE] (BC) or malignant melanoma (MM) have been performed in a southern European population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [20, 26], "entity_1_idx_in_text_with_entity_marker": [24, 30], "entity_1_idx_in_text_with_typed_entity_marker": [26, 32], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_238", "text": "The low frequencies of the at-risk alleles at rs1048661 and @GENE$ may be one of the factors that led to the low prevalence of @DISEASE$ in the general populations of the Chinese.", "text_with_entity_marker": "The low frequencies of the at-risk alleles at rs1048661 and [E1]@GENE$[/E1] may be one of the factors that led to the low prevalence of [E2]@DISEASE$[/E2] in the general populations of the Chinese.", "text_with_typed_entity_marker": "The low frequencies of the at-risk alleles at rs1048661 and [GENE]@GENE$[/GENE] may be one of the factors that led to the low prevalence of [DISEASE]@DISEASE$[/DISEASE] in the general populations of the Chinese.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [60, 66], "entity_1_idx_in_text_with_entity_marker": [64, 70], "entity_1_idx_in_text_with_typed_entity_marker": [66, 72], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [127, 136], "entity_2_idx_in_text_with_entity_marker": [140, 149], "entity_2_idx_in_text_with_typed_entity_marker": [149, 158], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_239", "text": "@GENE$ gene expression in @DISEASE$ cells significantly surpassed that in normal pancreatic cells.", "text_with_entity_marker": "[E1]@GENE$[/E1] gene expression in [E2]@DISEASE$[/E2] cells significantly surpassed that in normal pancreatic cells.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] gene expression in [DISEASE]@DISEASE$[/DISEASE] cells significantly surpassed that in normal pancreatic cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [26, 35], "entity_2_idx_in_text_with_entity_marker": [39, 48], "entity_2_idx_in_text_with_typed_entity_marker": [48, 57], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_240", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, @GENE$, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, [E2]@GENE$[/E2], Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, [GENE]@GENE$[/GENE], Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [540, 546], "entity_2_idx_in_text_with_entity_marker": [553, 559], "entity_2_idx_in_text_with_typed_entity_marker": [565, 571], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_241", "text": "This study provides epidemiologic evidence that the @GENE$ genotype is not associated with @DISEASE$ in old age.", "text_with_entity_marker": "This study provides epidemiologic evidence that the [E1]@GENE$[/E1] genotype is not associated with [E2]@DISEASE$[/E2] in old age.", "text_with_typed_entity_marker": "This study provides epidemiologic evidence that the [GENE]@GENE$[/GENE] genotype is not associated with [DISEASE]@DISEASE$[/DISEASE] in old age.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [52, 58], "entity_1_idx_in_text_with_entity_marker": [56, 62], "entity_1_idx_in_text_with_typed_entity_marker": [58, 64], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [91, 100], "entity_2_idx_in_text_with_entity_marker": [104, 113], "entity_2_idx_in_text_with_typed_entity_marker": [113, 122], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_242", "text": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including @DISEASE$ and squamous cell carcinoma, relatively little research has compared the effects of various @GENE$ inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "text_with_entity_marker": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including [E1]@DISEASE$[/E1] and squamous cell carcinoma, relatively little research has compared the effects of various [E2]@GENE$[/E2] inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "text_with_typed_entity_marker": "Although COX-2 is commonly overexpressed in a variety of premalignant and malignant conditions including [DISEASE]@DISEASE$[/DISEASE] and squamous cell carcinoma, relatively little research has compared the effects of various [GENE]@GENE$[/GENE] inhibitors (celecoxib, NS-398, nimesulide and meloxicam).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [105, 114], "entity_1_idx_in_text_with_entity_marker": [109, 118], "entity_1_idx_in_text_with_typed_entity_marker": [114, 123], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [207, 213], "entity_2_idx_in_text_with_entity_marker": [220, 226], "entity_2_idx_in_text_with_typed_entity_marker": [232, 238], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_243", "text": "@DISEASE$ is associated with decreased expression of mucosal @GENE$.", "text_with_entity_marker": "[E1]@DISEASE$[/E1] is associated with decreased expression of mucosal [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "[DISEASE]@DISEASE$[/DISEASE] is associated with decreased expression of mucosal [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [0, 9], "entity_1_idx_in_text_with_entity_marker": [4, 13], "entity_1_idx_in_text_with_typed_entity_marker": [9, 18], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [61, 67], "entity_2_idx_in_text_with_entity_marker": [74, 80], "entity_2_idx_in_text_with_typed_entity_marker": [86, 92], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_244", "text": "For the remaining markers, a susceptibility role was attributed also confirming that markers on @GENE$ gene, in particular G908R and L1007fsinsC, are involved with @DISEASE$ to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on [E1]@GENE$[/E1] gene, in particular G908R and L1007fsinsC, are involved with [E2]@DISEASE$[/E2] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "text_with_typed_entity_marker": "For the remaining markers, a susceptibility role was attributed also confirming that markers on [GENE]@GENE$[/GENE] gene, in particular G908R and L1007fsinsC, are involved with [DISEASE]@DISEASE$[/DISEASE] to the same extent as FcGIIIA G559T and TNF-alpha-G308A.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [96, 102], "entity_1_idx_in_text_with_entity_marker": [100, 106], "entity_1_idx_in_text_with_typed_entity_marker": [102, 108], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [164, 173], "entity_2_idx_in_text_with_entity_marker": [177, 186], "entity_2_idx_in_text_with_typed_entity_marker": [186, 195], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_245", "text": "On the other hand the frequency of @GENE$ genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian @DISEASE$ patients.", "text_with_entity_marker": "On the other hand the frequency of [E1]@GENE$[/E1] genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "On the other hand the frequency of [GENE]@GENE$[/GENE] genotype (p=0.028), IL-1R C pst1 1970 allele (p=0.0001) and CC genotype (p=0.00006), TNFalpha G -308 allele (p=0.0002) and GG genotype (p=0.000001) decreased significantly in the patients versus normal subjects.These results suggest that polymorphic variations of these pro-inflammatory cytokines may play an important role in susceptibility of Iranian [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [35, 41], "entity_1_idx_in_text_with_entity_marker": [39, 45], "entity_1_idx_in_text_with_typed_entity_marker": [41, 47], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [395, 404], "entity_2_idx_in_text_with_entity_marker": [408, 417], "entity_2_idx_in_text_with_typed_entity_marker": [417, 426], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_246", "text": "Elevation of @GENE$ expression in @DISEASE$ with Gsalpha protein mutation.", "text_with_entity_marker": "Elevation of [E1]@GENE$[/E1] expression in [E2]@DISEASE$[/E2] with Gsalpha protein mutation.", "text_with_typed_entity_marker": "Elevation of [GENE]@GENE$[/GENE] expression in [DISEASE]@DISEASE$[/DISEASE] with Gsalpha protein mutation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [13, 19], "entity_1_idx_in_text_with_entity_marker": [17, 23], "entity_1_idx_in_text_with_typed_entity_marker": [19, 25], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [34, 43], "entity_2_idx_in_text_with_entity_marker": [47, 56], "entity_2_idx_in_text_with_typed_entity_marker": [56, 65], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_247", "text": "Genetic variation in the promoter region of @GENE$ is associated with @DISEASE$.", "text_with_entity_marker": "Genetic variation in the promoter region of [E1]@GENE$[/E1] is associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Genetic variation in the promoter region of [GENE]@GENE$[/GENE] is associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [44, 50], "entity_1_idx_in_text_with_entity_marker": [48, 54], "entity_1_idx_in_text_with_typed_entity_marker": [50, 56], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [70, 79], "entity_2_idx_in_text_with_entity_marker": [83, 92], "entity_2_idx_in_text_with_typed_entity_marker": [92, 101], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_248", "text": "Expression of VEGFR-1 (@GENE$) in @DISEASE$ is associated with VEGF expression and with node-negative tumour stage.", "text_with_entity_marker": "Expression of VEGFR-1 ([E1]@GENE$[/E1]) in [E2]@DISEASE$[/E2] is associated with VEGF expression and with node-negative tumour stage.", "text_with_typed_entity_marker": "Expression of VEGFR-1 ([GENE]@GENE$[/GENE]) in [DISEASE]@DISEASE$[/DISEASE] is associated with VEGF expression and with node-negative tumour stage.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [23, 29], "entity_1_idx_in_text_with_entity_marker": [27, 33], "entity_1_idx_in_text_with_typed_entity_marker": [29, 35], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [34, 43], "entity_2_idx_in_text_with_entity_marker": [47, 56], "entity_2_idx_in_text_with_typed_entity_marker": [56, 65], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_249", "text": "Surprisingly, the @GENE$ allele is associated with a decreased incidence of @DISEASE$, suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "text_with_entity_marker": "Surprisingly, the [E1]@GENE$[/E1] allele is associated with a decreased incidence of [E2]@DISEASE$[/E2], suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "text_with_typed_entity_marker": "Surprisingly, the [GENE]@GENE$[/GENE] allele is associated with a decreased incidence of [DISEASE]@DISEASE$[/DISEASE], suggesting that Mycobacterium leprae subverts the TLR system as a mechanism of immune evasion.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [18, 24], "entity_1_idx_in_text_with_entity_marker": [22, 28], "entity_1_idx_in_text_with_typed_entity_marker": [24, 30], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [76, 85], "entity_2_idx_in_text_with_entity_marker": [89, 98], "entity_2_idx_in_text_with_typed_entity_marker": [98, 107], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_250", "text": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of @GENE$, significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.", "text_with_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of [E1]@GENE$[/E1], significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [E2]@DISEASE$[/E2] offspring were observed.", "text_with_typed_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of [GENE]@GENE$[/GENE], significant under-transmission for haplotype AG (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [DISEASE]@DISEASE$[/DISEASE] offspring were observed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [83, 89], "entity_1_idx_in_text_with_entity_marker": [87, 93], "entity_1_idx_in_text_with_typed_entity_marker": [89, 95], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [240, 249], "entity_2_idx_in_text_with_entity_marker": [253, 262], "entity_2_idx_in_text_with_typed_entity_marker": [262, 271], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_251", "text": "We failed to provide evidence of an association between @GENE$ and NOS1AP rs7538490 and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between [E1]@GENE$[/E1] and NOS1AP rs7538490 and type 2 diabetes, overweight, [E2]@DISEASE$[/E2] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between [GENE]@GENE$[/GENE] and NOS1AP rs7538490 and type 2 diabetes, overweight, [DISEASE]@DISEASE$[/DISEASE] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [56, 62], "entity_1_idx_in_text_with_entity_marker": [60, 66], "entity_1_idx_in_text_with_typed_entity_marker": [62, 68], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [117, 126], "entity_2_idx_in_text_with_entity_marker": [130, 139], "entity_2_idx_in_text_with_typed_entity_marker": [139, 148], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_252", "text": "@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of @DISEASE$ (HCC).", "text_with_entity_marker": "[E1]@GENE$[/E1] is a major enzyme in the bioactivation of exogenous procarcinogens of [E2]@DISEASE$[/E2] (HCC).", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] is a major enzyme in the bioactivation of exogenous procarcinogens of [DISEASE]@DISEASE$[/DISEASE] (HCC).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [77, 86], "entity_2_idx_in_text_with_entity_marker": [90, 99], "entity_2_idx_in_text_with_typed_entity_marker": [99, 108], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_253", "text": "Regulation of @GENE$ (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human @DISEASE$ cells.", "text_with_entity_marker": "Regulation of [E1]@GENE$[/E1] (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "Regulation of [GENE]@GENE$[/GENE] (HES-1) by estradiol and all-trans retinoic acid affects proliferation of human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [14, 20], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_idx_in_text_with_typed_entity_marker": [20, 26], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_254", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of @GENE$ showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of [E1]@GENE$[/E1] showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (rs10399805; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of [GENE]@GENE$[/GENE] showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [188, 194], "entity_1_idx_in_text_with_entity_marker": [192, 198], "entity_1_idx_in_text_with_typed_entity_marker": [194, 200], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [233, 242], "entity_2_idx_in_text_with_entity_marker": [246, 255], "entity_2_idx_in_text_with_typed_entity_marker": [255, 264], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_255", "text": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, @GENE$, and rs11594656) of the IL2RA in 885 patients with @DISEASE$ and 606 control subjects of Japanese origin.", "text_with_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, [E1]@GENE$[/E1], and rs11594656) of the IL2RA in 885 patients with [E2]@DISEASE$[/E2] and 606 control subjects of Japanese origin.", "text_with_typed_entity_marker": "We genotyped the four single-nucleotide polymorphisms (rs706778, rs3118470, [GENE]@GENE$[/GENE], and rs11594656) of the IL2RA in 885 patients with [DISEASE]@DISEASE$[/DISEASE] and 606 control subjects of Japanese origin.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [76, 82], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_idx_in_text_with_typed_entity_marker": [82, 88], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [134, 143], "entity_2_idx_in_text_with_entity_marker": [147, 156], "entity_2_idx_in_text_with_typed_entity_marker": [156, 165], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_256", "text": "Male @GENE$ SerSer carriers demonstrate particularly high @DISEASE$, possibly implying a status of increased cardiovascular risk.", "text_with_entity_marker": "Male [E1]@GENE$[/E1] SerSer carriers demonstrate particularly high [E2]@DISEASE$[/E2], possibly implying a status of increased cardiovascular risk.", "text_with_typed_entity_marker": "Male [GENE]@GENE$[/GENE] SerSer carriers demonstrate particularly high [DISEASE]@DISEASE$[/DISEASE], possibly implying a status of increased cardiovascular risk.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [5, 11], "entity_1_idx_in_text_with_entity_marker": [9, 15], "entity_1_idx_in_text_with_typed_entity_marker": [11, 17], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [58, 67], "entity_2_idx_in_text_with_entity_marker": [71, 80], "entity_2_idx_in_text_with_typed_entity_marker": [80, 89], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_257", "text": "@GENE$ contribute to the development of @DISEASE$ susceptibility in Middle Eastern population.", "text_with_entity_marker": "[E1]@GENE$[/E1] contribute to the development of [E2]@DISEASE$[/E2] susceptibility in Middle Eastern population.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] contribute to the development of [DISEASE]@DISEASE$[/DISEASE] susceptibility in Middle Eastern population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [40, 49], "entity_2_idx_in_text_with_entity_marker": [53, 62], "entity_2_idx_in_text_with_typed_entity_marker": [62, 71], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_258", "text": "In @DISEASE$ patients, TLR-induced GM-CSF secretion was impaired by both @GENE$-dependent and -independent mechanisms.", "text_with_entity_marker": "In [E1]@DISEASE$[/E1] patients, TLR-induced GM-CSF secretion was impaired by both [E2]@GENE$[/E2]-dependent and -independent mechanisms.", "text_with_typed_entity_marker": "In [DISEASE]@DISEASE$[/DISEASE] patients, TLR-induced GM-CSF secretion was impaired by both [GENE]@GENE$[/GENE]-dependent and -independent mechanisms.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [3, 12], "entity_1_idx_in_text_with_entity_marker": [7, 16], "entity_1_idx_in_text_with_typed_entity_marker": [12, 21], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [73, 79], "entity_2_idx_in_text_with_entity_marker": [86, 92], "entity_2_idx_in_text_with_typed_entity_marker": [98, 104], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_259", "text": "The @GENE$ variants was found to be irrelevant for @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] variants was found to be irrelevant for [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] variants was found to be irrelevant for [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_260", "text": "The @GENE$ pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the @DISEASE$.", "text_with_entity_marker": "The [E1]@GENE$[/E1] pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] pathway plays a pivotal role in the development of chronic mucosal inflammation seen in the [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_261", "text": "Our data provide the first evidence that the @GENE$ polymorphism is associated with decreased risk of @DISEASE$.", "text_with_entity_marker": "Our data provide the first evidence that the [E1]@GENE$[/E1] polymorphism is associated with decreased risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Our data provide the first evidence that the [GENE]@GENE$[/GENE] polymorphism is associated with decreased risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [102, 111], "entity_2_idx_in_text_with_entity_marker": [115, 124], "entity_2_idx_in_text_with_typed_entity_marker": [124, 133], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_262", "text": "Recently, mutations have been identified in the @GENE$ gene in Caucasian families with @DISEASE$.", "text_with_entity_marker": "Recently, mutations have been identified in the [E1]@GENE$[/E1] gene in Caucasian families with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Recently, mutations have been identified in the [GENE]@GENE$[/GENE] gene in Caucasian families with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_263", "text": "These results strongly suggest that the @GENE$ polymorphism in the CHI3L1 promoter region is associated with the risk of @DISEASE$.", "text_with_entity_marker": "These results strongly suggest that the [E1]@GENE$[/E1] polymorphism in the CHI3L1 promoter region is associated with the risk of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "These results strongly suggest that the [GENE]@GENE$[/GENE] polymorphism in the CHI3L1 promoter region is associated with the risk of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [40, 46], "entity_1_idx_in_text_with_entity_marker": [44, 50], "entity_1_idx_in_text_with_typed_entity_marker": [46, 52], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [121, 130], "entity_2_idx_in_text_with_entity_marker": [134, 143], "entity_2_idx_in_text_with_typed_entity_marker": [143, 152], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_264", "text": "We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (rs706778 and @GENE$).", "text_with_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [E1]@DISEASE$[/E1] for two of the four single-nucleotide polymorphisms genotyped (rs706778 and [E2]@GENE$[/E2]).", "text_with_typed_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [DISEASE]@DISEASE$[/DISEASE] for two of the four single-nucleotide polymorphisms genotyped (rs706778 and [GENE]@GENE$[/GENE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [171, 177], "entity_2_idx_in_text_with_entity_marker": [184, 190], "entity_2_idx_in_text_with_typed_entity_marker": [196, 202], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_265", "text": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region (@GENE$; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with @DISEASE$.", "text_with_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([E1]@GENE$[/E1]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In the case-control association analysis, the g.-247C/T polymorphism at the promoter region ([GENE]@GENE$[/GENE]; P = 0.0062) and the IVS7+82C/T polymorphism at intron 7 (rs2275353; P = 0.0056) of CHI3L1 showed a significant association with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [93, 99], "entity_1_idx_in_text_with_entity_marker": [97, 103], "entity_1_idx_in_text_with_typed_entity_marker": [99, 105], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [229, 238], "entity_2_idx_in_text_with_entity_marker": [242, 251], "entity_2_idx_in_text_with_typed_entity_marker": [251, 260], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_266", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and @GENE$, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and [E2]@GENE$[/E2], RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and [GENE]@GENE$[/GENE], RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [417, 423], "entity_2_idx_in_text_with_entity_marker": [430, 436], "entity_2_idx_in_text_with_typed_entity_marker": [442, 448], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_267", "text": "We failed to provide evidence of an association between PKLR rs3020781 and @GENE$ and type 2 diabetes, overweight, @DISEASE$ or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [E1]@GENE$[/E1] and type 2 diabetes, overweight, [E2]@DISEASE$[/E2] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "text_with_typed_entity_marker": "We failed to provide evidence of an association between PKLR rs3020781 and [GENE]@GENE$[/GENE] and type 2 diabetes, overweight, [DISEASE]@DISEASE$[/DISEASE] or related quantitative metabolic phenotypes in large-scale studies of Danes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [75, 81], "entity_1_idx_in_text_with_entity_marker": [79, 85], "entity_1_idx_in_text_with_typed_entity_marker": [81, 87], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [115, 124], "entity_2_idx_in_text_with_entity_marker": [128, 137], "entity_2_idx_in_text_with_typed_entity_marker": [137, 146], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_268", "text": "@GENE$-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in @DISEASE$ by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_entity_marker": "[E1]@GENE$[/E1]-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [E2]@DISEASE$[/E2] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE]-induced granulocyte-macrophage colony-stimulating factor secretion is impaired in [DISEASE]@DISEASE$[/DISEASE] by nucleotide oligomerization domain 2-dependent and -independent pathways.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [89, 98], "entity_2_idx_in_text_with_entity_marker": [102, 111], "entity_2_idx_in_text_with_typed_entity_marker": [111, 120], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_269", "text": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein (@GENE$, nucleotide oligomerization domain 2) are associated with Crohn's disease (@DISEASE$).", "text_with_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([E1]@GENE$[/E1], nucleotide oligomerization domain 2) are associated with Crohn's disease ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "Single nucleotide polymorphisms (SNPs) in the intracellular pattern recognition receptor nucleotide-binding oligomerization domain-containing protein ([GENE]@GENE$[/GENE], nucleotide oligomerization domain 2) are associated with Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [151, 157], "entity_1_idx_in_text_with_entity_marker": [155, 161], "entity_1_idx_in_text_with_typed_entity_marker": [157, 163], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [233, 242], "entity_2_idx_in_text_with_entity_marker": [246, 255], "entity_2_idx_in_text_with_typed_entity_marker": [255, 264], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_270", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, @GENE$ UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, [E2]@GENE$[/E2] UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, [GENE]@GENE$[/GENE] UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [428, 434], "entity_2_idx_in_text_with_entity_marker": [441, 447], "entity_2_idx_in_text_with_typed_entity_marker": [453, 459], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_271", "text": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase (@GENE$ gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and @DISEASE$.", "text_with_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([E1]@GENE$[/E1] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The K121Q polymorphism in the ectonucleotide pyrophosphatase/phosphodiesterase ([GENE]@GENE$[/GENE] gene and the rs7566605 genotype located near insulin-induced gene 2 have been shown to be associated with insulin resistance and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [80, 86], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_idx_in_text_with_typed_entity_marker": [86, 92], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [216, 225], "entity_2_idx_in_text_with_entity_marker": [229, 238], "entity_2_idx_in_text_with_typed_entity_marker": [238, 247], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_272", "text": "VEGF was expressed in 60% and @GENE$ in 39% of @DISEASE$ specimens.", "text_with_entity_marker": "VEGF was expressed in 60% and [E1]@GENE$[/E1] in 39% of [E2]@DISEASE$[/E2] specimens.", "text_with_typed_entity_marker": "VEGF was expressed in 60% and [GENE]@GENE$[/GENE] in 39% of [DISEASE]@DISEASE$[/DISEASE] specimens.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [30, 36], "entity_1_idx_in_text_with_entity_marker": [34, 40], "entity_1_idx_in_text_with_typed_entity_marker": [36, 42], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [47, 56], "entity_2_idx_in_text_with_entity_marker": [60, 69], "entity_2_idx_in_text_with_typed_entity_marker": [69, 78], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_273", "text": "Multiple studies have now established the contribution of the interleukin 23 receptor gene (@GENE$) to Crohn's disease (@DISEASE$) risk in general and of the IL23R R381Q variant in particular.", "text_with_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene ([E1]@GENE$[/E1]) to Crohn's disease ([E2]@DISEASE$[/E2]) risk in general and of the IL23R R381Q variant in particular.", "text_with_typed_entity_marker": "Multiple studies have now established the contribution of the interleukin 23 receptor gene ([GENE]@GENE$[/GENE]) to Crohn's disease ([DISEASE]@DISEASE$[/DISEASE]) risk in general and of the IL23R R381Q variant in particular.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [92, 98], "entity_1_idx_in_text_with_entity_marker": [96, 102], "entity_1_idx_in_text_with_typed_entity_marker": [98, 104], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [120, 129], "entity_2_idx_in_text_with_entity_marker": [133, 142], "entity_2_idx_in_text_with_typed_entity_marker": [142, 151], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_274", "text": "In this study, the @GENE$ polymorphism observed in the MDR1 gene was not found to be a risk factor for @DISEASE$ or ulcerative colitis.", "text_with_entity_marker": "In this study, the [E1]@GENE$[/E1] polymorphism observed in the MDR1 gene was not found to be a risk factor for [E2]@DISEASE$[/E2] or ulcerative colitis.", "text_with_typed_entity_marker": "In this study, the [GENE]@GENE$[/GENE] polymorphism observed in the MDR1 gene was not found to be a risk factor for [DISEASE]@DISEASE$[/DISEASE] or ulcerative colitis.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_275", "text": "Additionally, levels of @GENE$ were significantly lower in recalcitrant CRSwNP compared to controls and @DISEASE$.", "text_with_entity_marker": "Additionally, levels of [E1]@GENE$[/E1] were significantly lower in recalcitrant CRSwNP compared to controls and [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, levels of [GENE]@GENE$[/GENE] were significantly lower in recalcitrant CRSwNP compared to controls and [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [24, 30], "entity_1_idx_in_text_with_entity_marker": [28, 34], "entity_1_idx_in_text_with_typed_entity_marker": [30, 36], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [104, 113], "entity_2_idx_in_text_with_entity_marker": [117, 126], "entity_2_idx_in_text_with_typed_entity_marker": [126, 135], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_276", "text": "The @GENE$ polymorphism of COL1A2 could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.", "text_with_entity_marker": "The [E1]@GENE$[/E1] polymorphism of COL1A2 could be a genetic risk factor for sporadic [E2]@DISEASE$[/E2] among individuals of Chinese Han ethnicity.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] polymorphism of COL1A2 could be a genetic risk factor for sporadic [DISEASE]@DISEASE$[/DISEASE] among individuals of Chinese Han ethnicity.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [78, 87], "entity_2_idx_in_text_with_entity_marker": [91, 100], "entity_2_idx_in_text_with_typed_entity_marker": [100, 109], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_277", "text": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of @GENE$ haplotypes/diplotypes in 1006 pathologically confirmed @DISEASE$ patients and 1015 cancer-free controls, from a Han Chinese population.", "text_with_entity_marker": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of [E1]@GENE$[/E1] haplotypes/diplotypes in 1006 pathologically confirmed [E2]@DISEASE$[/E2] patients and 1015 cancer-free controls, from a Han Chinese population.", "text_with_typed_entity_marker": "In this study, we examined the association between HCC and four selected tagging single nucleotide polymorphisms (SNPs) of CYP1A1, and the risk of [GENE]@GENE$[/GENE] haplotypes/diplotypes in 1006 pathologically confirmed [DISEASE]@DISEASE$[/DISEASE] patients and 1015 cancer-free controls, from a Han Chinese population.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [147, 153], "entity_1_idx_in_text_with_entity_marker": [151, 157], "entity_1_idx_in_text_with_typed_entity_marker": [153, 159], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [209, 218], "entity_2_idx_in_text_with_entity_marker": [222, 231], "entity_2_idx_in_text_with_typed_entity_marker": [231, 240], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_278", "text": "Additionally, the PKLR and the @GENE$ genotypes were demonstrated not to have a major influence on @DISEASE$.", "text_with_entity_marker": "Additionally, the PKLR and the [E1]@GENE$[/E1] genotypes were demonstrated not to have a major influence on [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Additionally, the PKLR and the [GENE]@GENE$[/GENE] genotypes were demonstrated not to have a major influence on [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [99, 108], "entity_2_idx_in_text_with_entity_marker": [112, 121], "entity_2_idx_in_text_with_typed_entity_marker": [121, 130], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_279", "text": "@GENE$ genetic variations and susceptibility to @DISEASE$ in a Chinese population.", "text_with_entity_marker": "[E1]@GENE$[/E1] genetic variations and susceptibility to [E2]@DISEASE$[/E2] in a Chinese population.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genetic variations and susceptibility to [DISEASE]@DISEASE$[/DISEASE] in a Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_280", "text": "Amyloid beta protein (@GENE$) levels are elevated in the brain of @DISEASE$ patients.", "text_with_entity_marker": "Amyloid beta protein ([E1]@GENE$[/E1]) levels are elevated in the brain of [E2]@DISEASE$[/E2] patients.", "text_with_typed_entity_marker": "Amyloid beta protein ([GENE]@GENE$[/GENE]) levels are elevated in the brain of [DISEASE]@DISEASE$[/DISEASE] patients.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [66, 75], "entity_2_idx_in_text_with_entity_marker": [79, 88], "entity_2_idx_in_text_with_typed_entity_marker": [88, 97], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_281", "text": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for @GENE$ (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected @DISEASE$ offspring were observed.", "text_with_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for [E1]@GENE$[/E1] (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [E2]@DISEASE$[/E2] offspring were observed.", "text_with_typed_entity_marker": "In the haplotype-transmission disequilibrium test (TDT) for allelic combination of rs1937970-rs677221, significant under-transmission for [GENE]@GENE$[/GENE] (uncorrected p = .006) and over-transmission for haplotype GC (uncorrected p = .004) to the affected [DISEASE]@DISEASE$[/DISEASE] offspring were observed.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [138, 144], "entity_1_idx_in_text_with_entity_marker": [142, 148], "entity_1_idx_in_text_with_typed_entity_marker": [144, 150], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [246, 255], "entity_2_idx_in_text_with_entity_marker": [259, 268], "entity_2_idx_in_text_with_typed_entity_marker": [268, 277], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_282", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, @GENE$.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, Tp53 UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [639, 645], "entity_2_idx_in_text_with_entity_marker": [652, 658], "entity_2_idx_in_text_with_typed_entity_marker": [664, 670], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_283", "text": "Allelic composition at the examined SNPs in genes coding for @GENE$ and MMP-3 affect @DISEASE$ susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_entity_marker": "Allelic composition at the examined SNPs in genes coding for [E1]@GENE$[/E1] and MMP-3 affect [E2]@DISEASE$[/E2] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "text_with_typed_entity_marker": "Allelic composition at the examined SNPs in genes coding for [GENE]@GENE$[/GENE] and MMP-3 affect [DISEASE]@DISEASE$[/DISEASE] susceptibility and/or phenotype, i.e., fistulizing disease, stricture pathogenesis and first disease localisation.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [61, 67], "entity_1_idx_in_text_with_entity_marker": [65, 71], "entity_1_idx_in_text_with_typed_entity_marker": [67, 73], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [85, 94], "entity_2_idx_in_text_with_entity_marker": [98, 107], "entity_2_idx_in_text_with_typed_entity_marker": [107, 116], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_284", "text": "Our objective was to determine whether variants in the @GENE$ gene are associated with @DISEASE$ in the Japanese population.", "text_with_entity_marker": "Our objective was to determine whether variants in the [E1]@GENE$[/E1] gene are associated with [E2]@DISEASE$[/E2] in the Japanese population.", "text_with_typed_entity_marker": "Our objective was to determine whether variants in the [GENE]@GENE$[/GENE] gene are associated with [DISEASE]@DISEASE$[/DISEASE] in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [87, 96], "entity_2_idx_in_text_with_entity_marker": [100, 109], "entity_2_idx_in_text_with_typed_entity_marker": [109, 118], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_285", "text": "STEC strains carrying @GENE$ were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or @DISEASE$ than those carrying stx2vha.", "text_with_entity_marker": "STEC strains carrying [E1]@GENE$[/E1] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [E2]@DISEASE$[/E2] than those carrying stx2vha.", "text_with_typed_entity_marker": "STEC strains carrying [GENE]@GENE$[/GENE] were more frequently associated with clinical manifestations of hemolytic-uremic syndrome (HUS) or [DISEASE]@DISEASE$[/DISEASE] than those carrying stx2vha.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [22, 28], "entity_1_idx_in_text_with_entity_marker": [26, 32], "entity_1_idx_in_text_with_typed_entity_marker": [28, 34], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [128, 137], "entity_2_idx_in_text_with_entity_marker": [141, 150], "entity_2_idx_in_text_with_typed_entity_marker": [150, 159], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_286", "text": "The haplotypes constructed from the three SNPs (@GENE$, rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in @DISEASE$.", "text_with_entity_marker": "The haplotypes constructed from the three SNPs ([E1]@GENE$[/E1], rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "The haplotypes constructed from the three SNPs ([GENE]@GENE$[/GENE], rs3826047 and rs3743500, in order) in the 5'-upstream of NPTN showed a significant association with schizophrenia (permutation P=0.036), in that T-G-T (permutation P=0.028) and del-G-G (permutation P=0.040) were under-represented and over-represented, respectively, in [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [48, 54], "entity_1_idx_in_text_with_entity_marker": [52, 58], "entity_1_idx_in_text_with_typed_entity_marker": [54, 60], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [325, 334], "entity_2_idx_in_text_with_entity_marker": [338, 347], "entity_2_idx_in_text_with_typed_entity_marker": [347, 356], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_287", "text": "Two hundred and twenty-three incident @DISEASE$ cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, @GENE$ UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_entity_marker": "Two hundred and twenty-three incident [E1]@DISEASE$[/E1] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, [E2]@GENE$[/E2] UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "text_with_typed_entity_marker": "Two hundred and twenty-three incident [DISEASE]@DISEASE$[/DISEASE] cases and 229 controls recruited from Saudi Arabian population were analyzed for 21 loci in 8 selected DNA repair genes by PCR-restriction fragment length polymorphism including non-homologous end joining pathway genes LIGIV (LIGlV ASP62HIS, PRO231SER, TRP46TER), XRCC4 Splice 33243301G>A and XRCC7 ILE3434THR; homologous recombination pathway genes XRCC3 ARG94HIS and THR241MET, RAD51 UTR 15452658T>C, 15455419A>G, RAD52 2259 and GLN221GLU, conserved DNA damage response gene Tp53 PRO47SER, PRO72ARG, [GENE]@GENE$[/GENE] UTR 7178189A>C and base excision repair gene XRCC1 ARG194TRP, ARG280HIS, ARG399GLN, ARG559GLN.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [38, 47], "entity_1_idx_in_text_with_entity_marker": [42, 51], "entity_1_idx_in_text_with_typed_entity_marker": [47, 56], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [550, 556], "entity_2_idx_in_text_with_entity_marker": [563, 569], "entity_2_idx_in_text_with_typed_entity_marker": [575, 581], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_288", "text": "The 5T5T genotype at @GENE$ SNP -1613 5T/6T increased the chance of stenotic complications in @DISEASE$ during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_entity_marker": "The 5T5T genotype at [E1]@GENE$[/E1] SNP -1613 5T/6T increased the chance of stenotic complications in [E2]@DISEASE$[/E2] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "text_with_typed_entity_marker": "The 5T5T genotype at [GENE]@GENE$[/GENE] SNP -1613 5T/6T increased the chance of stenotic complications in [DISEASE]@DISEASE$[/DISEASE] during follow-up (91.2% vs 71.8%, P = 0.022) but seemed to protect against colonic involvement of this disease at first endoscopic/radiologic examination (35.3% vs 59.5%, P = 0.017).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [21, 27], "entity_1_idx_in_text_with_entity_marker": [25, 31], "entity_1_idx_in_text_with_typed_entity_marker": [27, 33], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [94, 103], "entity_2_idx_in_text_with_entity_marker": [107, 116], "entity_2_idx_in_text_with_typed_entity_marker": [116, 125], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_289", "text": "Polymorphisms in the regulatory region of the @GENE$ gene influence the susceptibility for HIV-1 @DISEASE$.", "text_with_entity_marker": "Polymorphisms in the regulatory region of the [E1]@GENE$[/E1] gene influence the susceptibility for HIV-1 [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Polymorphisms in the regulatory region of the [GENE]@GENE$[/GENE] gene influence the susceptibility for HIV-1 [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [97, 106], "entity_2_idx_in_text_with_entity_marker": [110, 119], "entity_2_idx_in_text_with_typed_entity_marker": [119, 128], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_290", "text": "@GENE$ genotyping might make tailor chemotherapy possible for @DISEASE$ patients treated with oxaliplatin-based chemotherapy.", "text_with_entity_marker": "[E1]@GENE$[/E1] genotyping might make tailor chemotherapy possible for [E2]@DISEASE$[/E2] patients treated with oxaliplatin-based chemotherapy.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] genotyping might make tailor chemotherapy possible for [DISEASE]@DISEASE$[/DISEASE] patients treated with oxaliplatin-based chemotherapy.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [62, 71], "entity_2_idx_in_text_with_entity_marker": [75, 84], "entity_2_idx_in_text_with_typed_entity_marker": [84, 93], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_291", "text": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus (@GENE$, rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term @DISEASE$ controllers.", "text_with_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus ([E1]@GENE$[/E1], rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [E2]@DISEASE$[/E2] controllers.", "text_with_typed_entity_marker": "Moreover, protective alleles for four disease-associated SNPs in the MHC locus ([GENE]@GENE$[/GENE], rs13199524, rs12198173 and rs3093662) were strikingly over-represented among forty-five Long Term [DISEASE]@DISEASE$[/DISEASE] controllers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [80, 86], "entity_1_idx_in_text_with_entity_marker": [84, 90], "entity_1_idx_in_text_with_typed_entity_marker": [86, 92], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [186, 195], "entity_2_idx_in_text_with_entity_marker": [199, 208], "entity_2_idx_in_text_with_typed_entity_marker": [208, 217], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_292", "text": "This study assessed associations between the @GENE$ gene and @DISEASE$ (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_entity_marker": "This study assessed associations between the [E1]@GENE$[/E1] gene and [E2]@DISEASE$[/E2] (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "text_with_typed_entity_marker": "This study assessed associations between the [GENE]@GENE$[/GENE] gene and [DISEASE]@DISEASE$[/DISEASE] (MI), using a haplotype-based case-control study of 234 MI patients and 248 controls genotyped for 5 single-nucleotide polymorphisms (rs3093105, rs3093135, rs1558139, rs2108622, rs3093200).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [61, 70], "entity_2_idx_in_text_with_entity_marker": [74, 83], "entity_2_idx_in_text_with_typed_entity_marker": [83, 92], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_293", "text": "Association of variants of the @GENE$ gene with susceptibility to @DISEASE$.", "text_with_entity_marker": "Association of variants of the [E1]@GENE$[/E1] gene with susceptibility to [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Association of variants of the [GENE]@GENE$[/GENE] gene with susceptibility to [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [31, 37], "entity_1_idx_in_text_with_entity_marker": [35, 41], "entity_1_idx_in_text_with_typed_entity_marker": [37, 43], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [66, 75], "entity_2_idx_in_text_with_entity_marker": [79, 88], "entity_2_idx_in_text_with_typed_entity_marker": [88, 97], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_294", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial @DISEASE$ (IAs) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial [E2]@DISEASE$[/E2] (IAs) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial [DISEASE]@DISEASE$[/DISEASE] (IAs) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [72, 81], "entity_2_idx_in_text_with_entity_marker": [85, 94], "entity_2_idx_in_text_with_typed_entity_marker": [94, 103], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_295", "text": "Previous studies of the @DISEASE$ have shown that @GENE$ and Chemokine receptor genetic variants influence disease progression and early viral load.", "text_with_entity_marker": "Previous studies of the [E1]@DISEASE$[/E1] have shown that [E2]@GENE$[/E2] and Chemokine receptor genetic variants influence disease progression and early viral load.", "text_with_typed_entity_marker": "Previous studies of the [DISEASE]@DISEASE$[/DISEASE] have shown that [GENE]@GENE$[/GENE] and Chemokine receptor genetic variants influence disease progression and early viral load.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [24, 33], "entity_1_idx_in_text_with_entity_marker": [28, 37], "entity_1_idx_in_text_with_typed_entity_marker": [33, 42], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [50, 56], "entity_2_idx_in_text_with_entity_marker": [63, 69], "entity_2_idx_in_text_with_typed_entity_marker": [75, 81], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_296", "text": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, @GENE$ (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of @DISEASE$ (IBD), that may enhance susceptibility and/or disease severity.", "text_with_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [E1]@GENE$[/E1] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [E2]@DISEASE$[/E2] (IBD), that may enhance susceptibility and/or disease severity.", "text_with_typed_entity_marker": "To study the (functional) relevance of single nucleotide polymorphisms (SNPs) in genes encoding matrix metalloproteinases (MMP)-1, -2, -3, -9, [GENE]@GENE$[/GENE] (TIMP)-1, -2 and tumor necrosis factor (TNF)-alpha in the etiopathogenesis of [DISEASE]@DISEASE$[/DISEASE] (IBD), that may enhance susceptibility and/or disease severity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [143, 149], "entity_1_idx_in_text_with_entity_marker": [147, 153], "entity_1_idx_in_text_with_typed_entity_marker": [149, 155], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [228, 237], "entity_2_idx_in_text_with_entity_marker": [241, 250], "entity_2_idx_in_text_with_typed_entity_marker": [250, 259], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_297", "text": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or @DISEASE$ compared to @GENE$ or His1104His genotypes.", "text_with_entity_marker": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or [E1]@DISEASE$[/E1] compared to [E2]@GENE$[/E2] or His1104His genotypes.", "text_with_typed_entity_marker": "Women carrying homozygous Asp1104Asp genotypes had a significantly decreased risk of cervical or [DISEASE]@DISEASE$[/DISEASE] compared to [GENE]@GENE$[/GENE] or His1104His genotypes.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [97, 106], "entity_1_idx_in_text_with_entity_marker": [101, 110], "entity_1_idx_in_text_with_typed_entity_marker": [106, 115], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [119, 125], "entity_2_idx_in_text_with_entity_marker": [132, 138], "entity_2_idx_in_text_with_typed_entity_marker": [144, 150], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_298", "text": "The @GENE$ gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms (@DISEASE$) in the Japanese population.", "text_with_entity_marker": "The [E1]@GENE$[/E1] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([E2]@DISEASE$[/E2]) in the Japanese population.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] gene at 7q22.1 has been shown to be associated with familial intracranial aneurysms ([DISEASE]@DISEASE$[/DISEASE]) in the Japanese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [96, 105], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_idx_in_text_with_typed_entity_marker": [118, 127], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_299", "text": "The @GENE$ variant of ENPP1 may be associated with @DISEASE$ viremia and core antigen levels in HCV carriers.", "text_with_entity_marker": "The [E1]@GENE$[/E1] variant of ENPP1 may be associated with [E2]@DISEASE$[/E2] viremia and core antigen levels in HCV carriers.", "text_with_typed_entity_marker": "The [GENE]@GENE$[/GENE] variant of ENPP1 may be associated with [DISEASE]@DISEASE$[/DISEASE] viremia and core antigen levels in HCV carriers.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [4, 10], "entity_1_idx_in_text_with_entity_marker": [8, 14], "entity_1_idx_in_text_with_typed_entity_marker": [10, 16], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [51, 60], "entity_2_idx_in_text_with_entity_marker": [64, 73], "entity_2_idx_in_text_with_typed_entity_marker": [73, 82], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_300", "text": "We found evidence of association with acute-onset, but not slow-onset and fulminant, @DISEASE$ for two of the four single-nucleotide polymorphisms genotyped (@GENE$ and rs3118470).", "text_with_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [E1]@DISEASE$[/E1] for two of the four single-nucleotide polymorphisms genotyped ([E2]@GENE$[/E2] and rs3118470).", "text_with_typed_entity_marker": "We found evidence of association with acute-onset, but not slow-onset and fulminant, [DISEASE]@DISEASE$[/DISEASE] for two of the four single-nucleotide polymorphisms genotyped ([GENE]@GENE$[/GENE] and rs3118470).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [85, 94], "entity_1_idx_in_text_with_entity_marker": [89, 98], "entity_1_idx_in_text_with_typed_entity_marker": [94, 103], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [158, 164], "entity_2_idx_in_text_with_entity_marker": [171, 177], "entity_2_idx_in_text_with_typed_entity_marker": [183, 189], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_301", "text": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and @GENE$ variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of @DISEASE$ (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [E1]@GENE$[/E1] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [E2]@DISEASE$[/E2] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "text_with_typed_entity_marker": "To summarise, we detected an increased HCC risk in rs4646421 variant carriers (OR 1.30, 95% CI 1.05-1.61) and [GENE]@GENE$[/GENE] variant carriers (OR 1.33, 95% CI 1.05-1.69), and a reduced risk of [DISEASE]@DISEASE$[/DISEASE] (OR 0.70. 95% CI 0.52-0.94) associated with homozygote carriers of rs4886605 variant.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [110, 116], "entity_1_idx_in_text_with_entity_marker": [114, 120], "entity_1_idx_in_text_with_typed_entity_marker": [116, 122], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [185, 194], "entity_2_idx_in_text_with_entity_marker": [198, 207], "entity_2_idx_in_text_with_typed_entity_marker": [207, 216], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_302", "text": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or @GENE$, is involved in the pathogenesis of @DISEASE$.", "text_with_entity_marker": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or [E1]@GENE$[/E1], is involved in the pathogenesis of [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Aberrant expression of chitinase 3-like 1 (CHI3L1), also known as YKL-40 or [GENE]@GENE$[/GENE], is involved in the pathogenesis of [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [76, 82], "entity_1_idx_in_text_with_entity_marker": [80, 86], "entity_1_idx_in_text_with_typed_entity_marker": [82, 88], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [119, 128], "entity_2_idx_in_text_with_entity_marker": [132, 141], "entity_2_idx_in_text_with_typed_entity_marker": [141, 150], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_303", "text": "The rs42524 polymorphism of @GENE$ could be a genetic risk factor for sporadic @DISEASE$ among individuals of Chinese Han ethnicity.", "text_with_entity_marker": "The rs42524 polymorphism of [E1]@GENE$[/E1] could be a genetic risk factor for sporadic [E2]@DISEASE$[/E2] among individuals of Chinese Han ethnicity.", "text_with_typed_entity_marker": "The rs42524 polymorphism of [GENE]@GENE$[/GENE] could be a genetic risk factor for sporadic [DISEASE]@DISEASE$[/DISEASE] among individuals of Chinese Han ethnicity.", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [79, 88], "entity_2_idx_in_text_with_entity_marker": [92, 101], "entity_2_idx_in_text_with_typed_entity_marker": [101, 110], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_304", "text": "In summary, we observed associations between @GENE$ gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with @DISEASE$.", "text_with_entity_marker": "In summary, we observed associations between [E1]@GENE$[/E1] gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In summary, we observed associations between [GENE]@GENE$[/GENE] gene and BC risk, and a comprehensive analysis using clinical and tumour characteristics as outcome variables has revealed potential associations with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [45, 51], "entity_1_idx_in_text_with_entity_marker": [49, 55], "entity_1_idx_in_text_with_typed_entity_marker": [51, 57], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [203, 212], "entity_2_idx_in_text_with_entity_marker": [216, 225], "entity_2_idx_in_text_with_typed_entity_marker": [225, 234], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_305", "text": "The low frequencies of the at-risk alleles at @GENE$ and rs2165241 may be one of the factors that led to the low prevalence of @DISEASE$ in the general populations of the Chinese.", "text_with_entity_marker": "The low frequencies of the at-risk alleles at [E1]@GENE$[/E1] and rs2165241 may be one of the factors that led to the low prevalence of [E2]@DISEASE$[/E2] in the general populations of the Chinese.", "text_with_typed_entity_marker": "The low frequencies of the at-risk alleles at [GENE]@GENE$[/GENE] and rs2165241 may be one of the factors that led to the low prevalence of [DISEASE]@DISEASE$[/DISEASE] in the general populations of the Chinese.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [46, 52], "entity_1_idx_in_text_with_entity_marker": [50, 56], "entity_1_idx_in_text_with_typed_entity_marker": [52, 58], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [127, 136], "entity_2_idx_in_text_with_entity_marker": [140, 149], "entity_2_idx_in_text_with_typed_entity_marker": [149, 158], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_306", "text": "@GENE$ is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma (@DISEASE$).", "text_with_entity_marker": "[E1]@GENE$[/E1] is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma ([E2]@DISEASE$[/E2]).", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] is a major enzyme in the bioactivation of exogenous procarcinogens of hepatocellular carcinoma ([DISEASE]@DISEASE$[/DISEASE]).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [103, 112], "entity_2_idx_in_text_with_entity_marker": [116, 125], "entity_2_idx_in_text_with_typed_entity_marker": [125, 134], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_307", "text": "Lysophosphatidic acid facilitates proliferation of @DISEASE$ cells via induction of @GENE$.", "text_with_entity_marker": "Lysophosphatidic acid facilitates proliferation of [E1]@DISEASE$[/E1] cells via induction of [E2]@GENE$[/E2].", "text_with_typed_entity_marker": "Lysophosphatidic acid facilitates proliferation of [DISEASE]@DISEASE$[/DISEASE] cells via induction of [GENE]@GENE$[/GENE].", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@DISEASE$", "entity_1_idx": [51, 60], "entity_1_idx_in_text_with_entity_marker": [55, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 69], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [84, 90], "entity_2_idx_in_text_with_entity_marker": [97, 103], "entity_2_idx_in_text_with_typed_entity_marker": [109, 115], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_308", "text": "Regulation of hairy and enhancer of split homologue-1 (@GENE$) by estradiol and all-trans retinoic acid affects proliferation of human @DISEASE$ cells.", "text_with_entity_marker": "Regulation of hairy and enhancer of split homologue-1 ([E1]@GENE$[/E1]) by estradiol and all-trans retinoic acid affects proliferation of human [E2]@DISEASE$[/E2] cells.", "text_with_typed_entity_marker": "Regulation of hairy and enhancer of split homologue-1 ([GENE]@GENE$[/GENE]) by estradiol and all-trans retinoic acid affects proliferation of human [DISEASE]@DISEASE$[/DISEASE] cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [55, 61], "entity_1_idx_in_text_with_entity_marker": [59, 65], "entity_1_idx_in_text_with_typed_entity_marker": [61, 67], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [135, 144], "entity_2_idx_in_text_with_entity_marker": [148, 157], "entity_2_idx_in_text_with_typed_entity_marker": [157, 166], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_309", "text": "In a family, we observed @GENE$ associated with @DISEASE$.", "text_with_entity_marker": "In a family, we observed [E1]@GENE$[/E1] associated with [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "In a family, we observed [GENE]@GENE$[/GENE] associated with [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [25, 31], "entity_1_idx_in_text_with_entity_marker": [29, 35], "entity_1_idx_in_text_with_typed_entity_marker": [31, 37], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [48, 57], "entity_2_idx_in_text_with_entity_marker": [61, 70], "entity_2_idx_in_text_with_typed_entity_marker": [70, 79], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_310", "text": "When stratified by @GENE$ polymorphism, alcohol-related increases in @DISEASE$ risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "text_with_entity_marker": "When stratified by [E1]@GENE$[/E1] polymorphism, alcohol-related increases in [E2]@DISEASE$[/E2] risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "text_with_typed_entity_marker": "When stratified by [GENE]@GENE$[/GENE] polymorphism, alcohol-related increases in [DISEASE]@DISEASE$[/DISEASE] risk were restricted to individuals with the AG/GG genotypes, with a more than 2-fold risk among daily drinkers (OR=2.63, 95% CI=1.00-6.88) and 3-fold risk (OR=3.66, 95% CI=1.19-11.24) among those with 40 or more drink-years.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [19, 25], "entity_1_idx_in_text_with_entity_marker": [23, 29], "entity_1_idx_in_text_with_typed_entity_marker": [25, 31], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [69, 78], "entity_2_idx_in_text_with_entity_marker": [82, 91], "entity_2_idx_in_text_with_typed_entity_marker": [91, 100], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_311", "text": "A recent study demonstrated the association of @GENE$ located in the upstream region with risk for or protection from @DISEASE$ (SLE).", "text_with_entity_marker": "A recent study demonstrated the association of [E1]@GENE$[/E1] located in the upstream region with risk for or protection from [E2]@DISEASE$[/E2] (SLE).", "text_with_typed_entity_marker": "A recent study demonstrated the association of [GENE]@GENE$[/GENE] located in the upstream region with risk for or protection from [DISEASE]@DISEASE$[/DISEASE] (SLE).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [47, 53], "entity_1_idx_in_text_with_entity_marker": [51, 57], "entity_1_idx_in_text_with_typed_entity_marker": [53, 59], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [118, 127], "entity_2_idx_in_text_with_entity_marker": [131, 140], "entity_2_idx_in_text_with_typed_entity_marker": [140, 149], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_312", "text": "The C-allele of PKLR rs3020781 and the @GENE$ are reported to strongly associate with @DISEASE$ in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_entity_marker": "The C-allele of PKLR rs3020781 and the [E1]@GENE$[/E1] are reported to strongly associate with [E2]@DISEASE$[/E2] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "text_with_typed_entity_marker": "The C-allele of PKLR rs3020781 and the [GENE]@GENE$[/GENE] are reported to strongly associate with [DISEASE]@DISEASE$[/DISEASE] in various European-descent populations comprising a total of 2,198 individuals with a combined odds ratio (OR) of 1.33 [1.16-1.54] and 1.53 [1.28-1.81], respectively.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [39, 45], "entity_1_idx_in_text_with_entity_marker": [43, 49], "entity_1_idx_in_text_with_typed_entity_marker": [45, 51], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [86, 95], "entity_2_idx_in_text_with_entity_marker": [99, 108], "entity_2_idx_in_text_with_typed_entity_marker": [108, 117], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_313", "text": "Compared to the most common @GENE$ haplotype CCAG, the haplotype TTGC conferred an increased risk of @DISEASE$ (OR 1.26, 95% CI 1.04-1.52).", "text_with_entity_marker": "Compared to the most common [E1]@GENE$[/E1] haplotype CCAG, the haplotype TTGC conferred an increased risk of [E2]@DISEASE$[/E2] (OR 1.26, 95% CI 1.04-1.52).", "text_with_typed_entity_marker": "Compared to the most common [GENE]@GENE$[/GENE] haplotype CCAG, the haplotype TTGC conferred an increased risk of [DISEASE]@DISEASE$[/DISEASE] (OR 1.26, 95% CI 1.04-1.52).", "relation": [{"relation_type": "negative", "relation_id": 0, "entity_1": "@GENE$", "entity_1_idx": [28, 34], "entity_1_idx_in_text_with_entity_marker": [32, 38], "entity_1_idx_in_text_with_typed_entity_marker": [34, 40], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [101, 110], "entity_2_idx_in_text_with_entity_marker": [114, 123], "entity_2_idx_in_text_with_typed_entity_marker": [123, 132], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_314", "text": "Vascular endothelial growth factor (VEGF) promotes @DISEASE$ progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 (@GENE$) expressed on tumour cells.", "text_with_entity_marker": "Vascular endothelial growth factor (VEGF) promotes [E1]@DISEASE$[/E1] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 ([E2]@GENE$[/E2]) expressed on tumour cells.", "text_with_typed_entity_marker": "Vascular endothelial growth factor (VEGF) promotes [DISEASE]@DISEASE$[/DISEASE] progression by inducing angiogenesis via VEGF receptors on endothelial cells but also signals directly through receptors such as VEGFR-1 ([GENE]@GENE$[/GENE]) expressed on tumour cells.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [51, 60], "entity_1_idx_in_text_with_entity_marker": [55, 64], "entity_1_idx_in_text_with_typed_entity_marker": [60, 69], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [199, 205], "entity_2_idx_in_text_with_entity_marker": [212, 218], "entity_2_idx_in_text_with_typed_entity_marker": [224, 230], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
{"id": "train_6_315", "text": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of @GENE$ but protects against @DISEASE$.", "text_with_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [E1]@GENE$[/E1] but protects against [E2]@DISEASE$[/E2].", "text_with_typed_entity_marker": "Cutting edge: A common polymorphism impairs cell surface trafficking and functional responses of [GENE]@GENE$[/GENE] but protects against [DISEASE]@DISEASE$[/DISEASE].", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [97, 103], "entity_1_idx_in_text_with_entity_marker": [101, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 109], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [125, 134], "entity_2_idx_in_text_with_entity_marker": [138, 147], "entity_2_idx_in_text_with_typed_entity_marker": [147, 156], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_316", "text": "@GENE$ predicts overall survival of @DISEASE$ patients receiving oxaliplatin-based chemotherapy in Chinese population.", "text_with_entity_marker": "[E1]@GENE$[/E1] predicts overall survival of [E2]@DISEASE$[/E2] patients receiving oxaliplatin-based chemotherapy in Chinese population.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] predicts overall survival of [DISEASE]@DISEASE$[/DISEASE] patients receiving oxaliplatin-based chemotherapy in Chinese population.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [36, 45], "entity_2_idx_in_text_with_entity_marker": [49, 58], "entity_2_idx_in_text_with_typed_entity_marker": [58, 67], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_317", "text": "The OR of the @GENE$ in our pediatric study is highly comparable with that reported previously in a non-Jewish adult @DISEASE$ case-control cohort (OR, 0.26).", "text_with_entity_marker": "The OR of the [E1]@GENE$[/E1] in our pediatric study is highly comparable with that reported previously in a non-Jewish adult [E2]@DISEASE$[/E2] case-control cohort (OR, 0.26).", "text_with_typed_entity_marker": "The OR of the [GENE]@GENE$[/GENE] in our pediatric study is highly comparable with that reported previously in a non-Jewish adult [DISEASE]@DISEASE$[/DISEASE] case-control cohort (OR, 0.26).", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [14, 20], "entity_1_idx_in_text_with_entity_marker": [18, 24], "entity_1_idx_in_text_with_typed_entity_marker": [20, 26], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [117, 126], "entity_2_idx_in_text_with_entity_marker": [130, 139], "entity_2_idx_in_text_with_typed_entity_marker": [139, 148], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_318", "text": "@GENE$ interacts directly with the malate shuttle system, which has been shown to be altered in @DISEASE$ and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_entity_marker": "[E1]@GENE$[/E1] interacts directly with the malate shuttle system, which has been shown to be altered in [E2]@DISEASE$[/E2] and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "text_with_typed_entity_marker": "[GENE]@GENE$[/GENE] interacts directly with the malate shuttle system, which has been shown to be altered in [DISEASE]@DISEASE$[/DISEASE] and bipolar disorder, and has roles in neuronal synthesis of glutamate and gamma-amino butyric acid.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@GENE$", "entity_1_idx": [0, 6], "entity_1_idx_in_text_with_entity_marker": [4, 10], "entity_1_idx_in_text_with_typed_entity_marker": [6, 12], "entity_1_type": "GENE", "entity_1_type_id": 0, "entity_2": "@DISEASE$", "entity_2_idx": [96, 105], "entity_2_idx_in_text_with_entity_marker": [109, 118], "entity_2_idx_in_text_with_typed_entity_marker": [118, 127], "entity_2_type": "DISEASE", "entity_2_type_id": 1}]}
{"id": "train_6_319", "text": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of @DISEASE$ and intestinal cancer in @GENE$ and GPx2 double knockout mice.", "text_with_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [E1]@DISEASE$[/E1] and intestinal cancer in [E2]@GENE$[/E2] and GPx2 double knockout mice.", "text_with_typed_entity_marker": "An anti-inflammatory and anticarcinogenic potential has been inferred from the development of [DISEASE]@DISEASE$[/DISEASE] and intestinal cancer in [GENE]@GENE$[/GENE] and GPx2 double knockout mice.", "relation": [{"relation_type": "positive", "relation_id": 1, "entity_1": "@DISEASE$", "entity_1_idx": [94, 103], "entity_1_idx_in_text_with_entity_marker": [98, 107], "entity_1_idx_in_text_with_typed_entity_marker": [103, 112], "entity_1_type": "DISEASE", "entity_1_type_id": 1, "entity_2": "@GENE$", "entity_2_idx": [129, 135], "entity_2_idx_in_text_with_entity_marker": [142, 148], "entity_2_idx_in_text_with_typed_entity_marker": [154, 160], "entity_2_type": "GENE", "entity_2_type_id": 0}]}
